Archive for July, 2011

Scorpex (SRPX) Signs Multi-Million Dollar Contract to Secure Waste Processing Equipment for Initial Facility

LAS VEGAS, NV–(Marketwire – July 27, 2011) – Scorpex, Inc. (PINKSHEETS: SRPX) (the “Company”), an emerging leader of industrial, hazardous and toxic waste disposal services in the Baja Mexico/California region, today announces it has entered into a major agreement with International Environmental Technologies, Inc. (“IET”) for the acquisition and installation of waste gasification/thermal oxidation equipment as well as a license to use the technology.

IET’s patented technology is capable of processing municipal waste, medical waste and hazardous waste simultaneously without presorting for maximum efficiency. The oxygen starved system virtually eliminates noise and noxious odors when operating while reducing waste volume by 95%. The design of the system also reduces breeding sites for scavengers, rodents, insects and disease that are sometimes found in other processes.

Chief Executive Officer Joseph Caywood commented, “Following our evaluation of various waste processing techniques and technologies, we found the solution offered by IET to be superior to those offered by competitors. Securing this technology was a crucial part of our business plan. We will provide additional details very soon.”

About Scorpex, Inc.

Scorpex, Inc. is taking the necessary steps to own and operate a full service waste disposal and recycling company, capable of storing and disposing all types of waste, including those classified as industrial, toxic, and hazardous. The location chosen for the first Scorpex plant is strategically positioned to accommodate the vast region of Baja California, Mexico.

For more information, visit www.scorpex.com

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. Through a full suite of investor relations and consultancy services, we help public companies develop and execute a strategic investor awareness plan as we’ve done for hundreds of others. Whether it is capital raising, increasing awareness among the financial community, or enhancing corporate communications, we offer a variety of solutions to meet the objectives of our clients.

For more information on Scorpex, Inc., visit http://SRPX.MissionIR.com

This press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Wednesday, July 27th, 2011 Uncategorized Comments Off on Scorpex (SRPX) Signs Multi-Million Dollar Contract to Secure Waste Processing Equipment for Initial Facility

China Nutrifruit (CNGL) Withdraws Registration Statement on Form S-1 and Application for TDR Listing

DAQING, China, June 23, 2011 /PRNewswire-Asia-FirstCall/ — China Nutrifruit Group Limited (NYSE Amex: CNGL) (“China Nutrifruit” or “the Company”), a leading producer of premium specialty fruit based products in China (“PRC”), today announced that it has filed an application with the Securities and Exchange Commission to withdraw its registration statement on Form S-1, Registration No. 333-171286, for a proposed offering of 73,000,000 units of Taiwan Depositary Receipt (the “TDRs”), representing 7,300,000 shares of the Company’s common stock. The Company also withdrew its application for listing the TDRs on the Taiwan Stock Exchange.

“After careful considerations, we have decided not to pursue the TDR listing due to uncertainties in the global capital markets. We believe it is in our shareholders’ best interest to withdraw the application given the current market volatility,” said Mr. Changjun Yu, Chairman and CEO of China Nutrifruit.

About China Nutrifruit Group Limited

Through its subsidiaries Daqing Longheda Food Company Limited and Daqing Senyang Fruit and Vegetable Food Technology Company Limited, China Nutrifruit, is engaged in developing, processing, marketing and distributing a variety of food products processed primarily from premium specialty fruits grown in Northeast China, including golden berry, crab apple, blueberry, seabuckthorn, blackcurrant and raspberry. Its processing facility possesses ISO9001 and HACCP series qualifications. Currently, the Company has established an extensive nationwide sales and distribution network throughout 18 provinces in China. For more information, please visit http://www.chinanutrifruit.com .

Company Contact:

Investor Relations Contact:

Mr. Colman Cheng, Chief Financial Officer

Mr. Crocker Coulson, President

China Nutrifruit Group Limited

CCG Investor Relations

Tel: +852-9039-8111

Tel: +1-646-213-1915 (NY office)

Email: zsj@chinanutrifruit.com

Email: crocker.coulson@ccgir.com

Website: www.chinanutrifruit.com

Website: www.ccgirasia.com

Linda Salo, Account Manager

Tel: +1-646-922-0894 (NY office)

Email: linda.salo@ccgir.com

Wednesday, July 27th, 2011 Uncategorized Comments Off on China Nutrifruit (CNGL) Withdraws Registration Statement on Form S-1 and Application for TDR Listing

Acxiom (ACXM) Announces First Quarter Fiscal Year 2012 Results

Jul. 27, 2011 (Business Wire) — Acxiom® Corporation (Nasdaq: ACXM), a recognized leader in marketing services and technology, today announced financial results for the first quarter of fiscal year 2012 ended June 30, 2011. Acxiom will hold a conference call at 9:00 a.m. CDT today to further discuss this information. Interested parties are invited to listen to the call, which will be broadcast via the Internet at www.acxiom.com.

Jerry Gramaglia, Acxiom’s interim chief executive officer, said, “We achieved overall solid financial performance for the quarter and are pleased with our continued revenue growth, especially in our core U.S. marketing services and products business. During the quarter we increased spending in sales, account management and service delivery to continue our momentum and position Acxiom for strong performance through the balance of the year.”

First Quarter 2012 Highlights:

  • Revenue increased by 6.9% in the current quarter ended June 30, 2011 to $288.9 million, compared to $270.4 million for the quarter ended June 30, 2010.
  • Income from operations of $22.2 million in the current-year first quarter, compared to income from operations of $22.1 million in the first quarter of the prior year.
  • Earnings per diluted share attributable to Acxiom stockholders of $0.13 in the current quarter, compared to earnings per share of $0.12 in the first quarter of fiscal 2011.
  • Operating cash flow of $32.8 million, compared to $17.0 million in the first quarter a year ago.
  • Free cash flow available to equity of $9.6 million, compared to negative $6.3 million in the first quarter a year ago. Free cash flow available to equity is a non-GAAP financial measure; a reconciliation to the comparable GAAP measure, operating cash flow, is attached to this news release.

Operational Highlights:

  • Information Services: Revenue for the quarter ended June 30, 2011 was $225.6 million, up 7.1%, compared to $210.7 million for the quarter ended June 30, 2010. Income from operations for the current first quarter was $20.2 million, down 3.4% compared to $20.9 million in the prior-year first quarter.
  • Information Products: Revenue for the quarter increased 6.0% to $63.3 million, compared with $59.7 million in the first quarter a year ago. Income from operations for the quarter was $2.3 million, compared to $1.1 million in the first quarter of the previous year.
  • Debt prepayment: The company prepaid $25 million of its term loan due March 15, 2015 in the current quarter. Subsequent to the end of the June 30, 2011 quarter, the company prepaid an additional $75 million of the term loan.
  • Middle East and North Africa (MENA) disposal: Subsequent to the end of the June 30, 2011 quarter, the company disposed of its ownership interest in MENA.

Web Link to Financials

You may link to http://www.acxiom.com/FY12_Q1_Financials for the detailed financial information we typically attach to our earnings releases.

About Acxiom

Acxiom is a recognized leader in marketing services and technology that enable marketers to successfully manage audiences, personalize consumer experiences and create profitable customer relationships. Our superior industry-focused, consultative approach combines consumer data and analytics, databases, data integration and consulting solutions for personalized, multichannel marketing strategies. Acxiom leverages over 40 years of experience in data management to deliver high-performance, highly secure, reliable information management services. Founded in 1969, Acxiom is headquartered in Little Rock, Arkansas, USA, and serves clients around the world from locations in the United States, Europe, Asia-Pacific, and South America. For more information about Acxiom, visit Acxiom.com.

Forward Looking Statements

This release and today’s conference call may contain forward-looking statements including, without limitation, statements regarding our expectation for strong performance for the balance of the year. Such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially. The following are factors, among others, that could cause actual results to differ materially from these forward-looking statements: the possibility that certain contracts may not generate the anticipated revenue or profitability or may not be closed within the anticipated time frames; the possibility that significant customers may experience extreme, severe economic difficulty or otherwise reduce the amount of business they do with us; the possibility that we will not successfully complete customer contract requirements on time or meet the service levels specified in the contracts, which may result in contract penalties or lost revenue; the possibility that data suppliers might withdraw data from us, leading to our inability to provide certain products and services to our clients, which could lead to decreases in our operating results; the possibility that we may not be able to attract, retain or motivate qualified technical, sales and leadership associates, or that we may lose key associates; the possibility that we may be unable to quickly and seamlessly integrate a new chief executive officer and chief financial officer; the possibility that we will not be able to continue to receive credit upon satisfactory terms and conditions; the possibility that negative changes in economic conditions in general or other conditions might lead to a reduction in demand for our products and services; the possibility that there will be changes in consumer or business information industries and markets that negatively impact the company; the possibility that the historical seasonality of our business may change; the possibility that we will not be able to achieve cost reductions and avoid unanticipated costs; the possibility that the fair value of certain of our assets may not be equal to the carrying value of those assets now or in future time periods; the possibility that changes in accounting pronouncements may occur and may impact these forward-looking statements; the possibility that we may encounter difficulties when entering new markets or industries; the possibility that we could experience loss of data center capacity or interruption of telecommunication links; and other risks and uncertainties, including those detailed from time to time in our periodic reports filed with the Securities and Exchange Commission, including our current reports on Form 8-K, quarterly reports on Form 10-Q and annual reports on Form 10-K, particularly the discussion under the caption “Item 1A, RISK FACTORS” in our Annual Reports on Form 10-K for the year ended March 31, 2011, which was filed with the Securities and Exchange Commission on May 27, 2011.

With respect to the provision of products or services outside our primary base of operations in the United States, all of the above factors apply, along with the difficulty of doing business in numerous sovereign jurisdictions due to differences in scale, competition, culture, laws and regulations.

We undertake no obligation to update the information contained in this press release or any other forward-looking statement.

Acxiom is a registered trademark of Acxiom Corporation.

ACXIOM CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands, except earnings per share)
For the Three Months Ended
June 30,
$ %
2011 2010 Variance Variance
Revenue:
Services 225,604 210,656 14,948 7.1 %
Products 63,330 59,739 3,591 6.0 %
Total revenue 288,934 270,395 18,539 6.9 %
Operating costs and expenses:
Cost of revenue
Services 180,463 164,650 (15,813 ) (9.6 %)
Products 48,878 45,771 (3,107 ) (6.8 %)
Total cost of revenue 229,341 210,421 (18,920 ) (9.0 %)
Services gross margin 20.0 % 21.8 %
Products gross margin 22.8 % 23.4 %
Total gross margin 20.6 % 22.2 %
Selling, general and administrative 37,119 37,955 836 2.2 %
Gains, losses and other items, net 244 (57 ) (301 ) (528.1 %)
Total operating costs and expenses 266,704 248,319 (18,385 ) (7.4 %)
Income from operations 22,230 22,076 154 0.7 %
Other income (expense):
Interest expense (5,455 ) (5,898 ) 443 7.5 %
Other, net (87 ) (451 ) 364 80.7 %
Total other income (expense) (5,542 ) (6,349 ) 807 12.7 %
Earnings before income taxes 16,688 15,727 961 6.1 %
Income taxes 6,673 6,291 (382 ) (6.1 %)
Net earnings 10,015 9,436 579 6.1 %
Less: Net earnings (loss) attributable to noncontrolling interest (960 ) (369 ) (591 )
Net earnings attributable to Acxiom 10,975 9,805 1,170 11.9 %
Earnings per share:
Basic 0.12 0.12 0.00 0.0 %
Diluted 0.12 0.12 0.00 0.0 %
Earnings per share attributable to Acxiom stockholders:
Basic 0.14 0.12 0.02 16.7 %
Diluted 0.13 0.12 0.01 8.3 %
ACXIOM CORPORATION AND SUBSIDIARIES
CALCULATION OF EARNINGS PER SHARE
(Unaudited)
(In thousands, except earnings per share)
For the Three Months Ended
June 30, June 30,
2011 2010
Basic earnings per share:
Numerator – net earnings 10,015 9,436
Denominator – weighted-average shares outstanding 80,942 79,741
Basic earnings per share 0.12 0.12
Diluted earnings per share:
Numerator – net earnings 10,015 9,436
Denominator – weighted-average shares outstanding 80,942 79,741
Dilutive effect of common stock options, warrants and restricted stock 1,072 1,715
82,014 81,456
Diluted earnings per share 0.12 0.12
Basic earnings per share attributable to Acxiom stockholders:
Numerator – net earnings attributable to Acxiom 10,975 9,805
Denominator – weighted-average shares outstanding 80,942 79,741
Basic earnings per share attributable to Acxiom stockholders 0.14 0.12
Diluted earnings per share attributable to Acxiom stockholders:
Numerator – net earnings attributable to Acxiom 10,975 9,805
Denominator – weighted-average shares outstanding 80,942 79,741
Dilutive effect of common stock options, warrants, and restricted stock 1,072 1,715
82,014 81,456
Diluted earnings per share attributable to Acxiom stockholders 0.13 0.12
ACXIOM CORPORATION AND SUBSIDIARIES
RESULTS BY SEGMENT
(Unaudited)
(Dollars in thousands)
For the Three Months Ended
June 30, June 30,
Revenue: 2011 2010
Information services 225,604 210,656
Information products 63,330 59,739
Total revenue 288,934 270,395
Income from operations:
Information services 20,172 20,879
Information products 2,302 1,140
Other (244 ) 57
Total income from operations 22,230 22,076
Margin:
Information services 8.9 % 9.9 %
Information products 3.6 % 1.9 %
Total margin 7.7 % 8.2 %
ACXIOM CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in thousands)
June 30, March 31, $ %
2011 2011 Variance Variance
Assets
Current assets:
Cash and cash equivalents 191,094 207,023 (15,929 ) (7.7 %)
Trade accounts receivable, net 180,610 176,654 3,956 2.2 %
Deferred income taxes 12,773 12,480 293 2.3 %
Refundable income taxes 1,900 7,402 (5,502 ) (74.3 %)
Other current assets 64,156 55,691 8,465 15.2 %
Total current assets 450,533 459,250 (8,717 ) (1.9 %)
Property and equipment 899,047 888,717 10,330 1.2 %
Less – accumulated depreciation and amortization 643,618 633,410 10,208 1.6 %
Property and equipment, net 255,429 255,307 122 0.0 %
Software, net of accumulated amortization 22,896 26,412 (3,516 ) (13.3 %)
Goodwill 418,988 417,654 1,334 0.3 %
Purchased software licenses, net of accumulated amortization 36,067 38,583 (2,516 ) (6.5 %)
Deferred costs, net 75,757 81,837 (6,080 ) (7.4 %)
Data acquisition costs 16,976 17,627 (651 ) (3.7 %)
Other assets, net 8,579 9,955 (1,376 ) (13.8 %)
1,285,225 1,306,625 (21,400 ) (1.6 %)
Liabilities and Stockholders’ Equity
Current liabilities:
Current installments of long-term debt 28,112 27,978 (134 ) (0.5 %)
Trade accounts payable 28,999 27,507 (1,492 ) (5.4 %)
Accrued payroll and related expenses 30,893 42,236 11,343 26.9 %
Other accrued expenses 76,831 75,852 (979 ) (1.3 %)
Deferred revenue 57,426 55,921 (1,505 ) (2.7 %)
Total current liabilities 222,261 229,494 7,233 3.2 %
Long-term debt 365,565 394,260 28,695 7.3 %
Deferred income taxes 84,446 84,360 (86 ) (0.1 %)
Other liabilities 6,505 7,478 973 13.0 %
Stockholders’ equity:
Common stock 11,879 11,777 102 0.9 %
Additional paid-in capital 842,655 837,439 5,216 0.6 %
Retained earnings 470,071 459,096 10,975 2.4 %
Accumulated other comprehensive income (loss) 18,997 15,991 3,006 18.8 %
Treasury stock, at cost (742,049 ) (739,125 ) (2,924 ) 0.4 %
Total Acxiom stockholders’ equity 601,553 585,178 16,375 2.8 %
Noncontrolling interest 4,895 5,855 (960 ) (16.4 %)
Total equity 606,448 591,033 15,415 2.6 %
1,285,225 1,306,625 (21,400 ) (1.6 %)
ACXIOM CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
(Dollars in thousands)
For the Three Months Ended
June 30,
2011 2010
Cash flows from operating activities:
Net earnings 10,015 9,436
Non-cash operating activities:
Depreciation and amortization 35,295 35,986
Deferred income taxes 37 1,435
Non-cash stock compensation expense 2,355 2,972
Changes in operating assets and liabilities:
Accounts receivable (3,622) (16,836)
Other assets (8,517) (1,467)
Deferred costs (386) (9,981)
Accounts payable and other liabilities (3,674) (7,121)
Deferred revenue 1,251 2,564
Net cash provided by operating activities 32,754 16,988
Cash flows from investing activities:
Capitalized software (529) (1,226)
Capital expenditures (12,577) (8,752)
Data acquisition costs (2,776) (4,326)
Payment received from investments 175
Net cash paid in acquisitions (255) (1,978)
Net cash used by investing activities (16,137) (16,107)
Cash flows from financing activities:
Payments of debt (32,312) (8,964)
Sale of common stock 39 3,801
Contingent consideration paid for prior acquisitions (326)
Net cash used by financing activities (32,599) (5,163)
Effect of exchange rate changes on cash 53 (1,365)
Net change in cash and cash equivalents (15,929) (5,647)
Cash and cash equivalents at beginning of period 207,023 224,104
Cash and cash equivalents at end of period 191,094 218,457
Supplemental cash flow information:
Cash paid (received) during the period for:
Interest 5,589 5,780
Income taxes 1,098 3,358
Payments on capital leases and installment payment arrangements 4,794 5,968
Payments on software and data license liabilities 367 893
Other debt payments, excluding line of credit 2,151 2,103
Prepayments of debt 25,000
Noncash investing and financing activities:
Acquisition of property and equipment under capital lease and installment payment arrangements 3,747 10,268
ACXIOM CORPORATION AND SUBSIDIARIES
CALCULATION OF FREE CASH FLOW AVAILABLE TO EQUITY
AND RECONCILIATION TO OPERATING CASH FLOW
(Unaudited)
(Dollars in thousands)
06/30/10 09/30/10 12/31/10 03/31/11 FY2011 06/30/11
Net cash provided by operating activities 16,988 42,966 64,230 42,035 166,219 32,754
Plus:
Sale of assets
Less:
Capitalized software (1,226 ) (1,341 ) (1,025 ) (963 ) (4,555 ) (529 )
Capital expenditures (8,752 ) (21,734 ) (16,322 ) (12,213 ) (59,021 ) (12,577 )
Data acquisition costs (4,326 ) (2,625 ) (3,765 ) (2,650 ) (13,366 ) (2,776 )
Payments on capital leases and installment payment arrangements (5,968 ) (5,411 ) (5,726 ) (5,252 ) (22,357 ) (4,794 )
Payments on software and data license liabilities (893 ) (164 ) (120 ) (4,139 ) (5,316 ) (367 )
Other required debt payments (2,103 ) (2,028 ) (2,143 ) (2,154 ) (8,428 ) (2,151 )
Total (6,280 ) 9,663 35,129 14,664 53,176 9,560
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in thousands, except earnings per share)
Q1 FY12 to Q1 FY11
06/30/10 09/30/10 12/31/10 03/31/11 FY2011 06/30/11 % $
Revenue:
Services 210,656 225,584 232,798 224,556 893,594 225,604 7.1 % 14,948
Products 59,739 66,085 66,312 74,240 266,376 63,330 6.0 % 3,591
Total revenue 270,395 291,669 299,110 298,796 1,159,970 288,934 6.9 % 18,539
Operating costs and expenses:
Cost of revenue
Services 164,650 175,687 178,586 176,065 694,988 180,463 -9.6 % (15,813 )
Products 45,771 48,320 48,258 47,551 189,900 48,878 -6.8 % (3,107 )
Total cost of revenue 210,421 224,007 226,844 223,616 884,888 229,341 -9.0 % (18,920 )
Selling, general and administrative 37,955 40,274 41,331 40,324 159,884 37,119 2.2 % 836
Impairment of goodwill and other intangibles 79,674 79,674 0
Gains, losses and other items, net (57 ) 78 (3,640 ) 8,219 4,600 244 -528.1 % (301 )
Total operating costs and expenses 248,319 264,359 264,535 351,833 1,129,046 266,704 -7.4 % (18,385 )
Income from operations 22,076 27,310 34,575 (53,037 ) 30,924 22,230 0.7 % 154
% Margin 8.2 % 9.4 % 11.6 % -17.8 % 2.7 % 7.7 %
Other income (expense)
Interest expense (5,898 ) (6,260 ) (6,006 ) (5,659 ) (23,823 ) (5,455 ) 7.5 % (443 )
Other, net (451 ) 111 (299 ) (827 ) (1,466 ) (87 ) 80.7 % (364 )
Total other income (expense) (6,349 ) (6,149 ) (6,305 ) (6,486 ) (25,289 ) (5,542 ) 12.7 % (807 )
Earnings before income taxes 15,727 21,161 28,270 (59,523 ) 5,635 16,688 6.1 % 961
Income taxes 6,291 8,464 7,856 11,466 34,077 6,673 -6.1 % (382 )
Net earnings (loss) 9,436 12,697 20,414 (70,989 ) (28,442 ) 10,015 6.1 % 579
Less: Net loss attributable to noncontrolling interest (369 ) (584 ) (409 ) (3,933 ) (5,295 ) (960 ) 160.2 % (591 )
Net earnings (loss) attributable to Acxiom 9,805 13,281 20,823 (67,056 ) (23,147 ) 10,975 11.9 % 1,170
Diluted earnings (loss) per share attributable to Acxiom shareholders 0.12 0.16 0.25 (0.83 ) (0.29 ) 0.13 8.3 % 0.01
ACXIOM CORPORATION AND SUBSIDIARIES
RESULTS BY SEGMENT
(Unaudited)
(Dollars in thousands)
Q1 FY11 to Q1 FY12
06/30/10 09/30/10 12/31/10 03/31/11 FY2011 06/30/11 % $
Revenue:
Services 210,656 225,584 232,798 224,556 893,594 225,604 7.1 % 14,948
Products 59,739 66,085 66,312 74,240 266,376 63,330 6.0 % 3,591
Total revenue 270,395 291,669 299,110 298,796 1,159,970 288,934 6.9 % 18,539
Income from operations:
Services 20,879 22,952 26,390 21,181 91,402 20,172 -3.4 % (707 )
Products 1,140 4,436 4,545 13,675 23,796 2,302 101.9 % 1,162
Other 57 (78 ) 3,640 (87,893 ) (84,274 ) (244 ) -528.1 % (301 )
Total income (loss) from operations 22,076 27,310 34,575 (53,037 ) 30,924 22,230 0.7 % 154
Margin:
Services 9.9 % 10.2 % 11.3 % 9.4 % 10.2 % 8.9 %
Products 1.9 % 6.7 % 6.9 % 18.4 % 8.9 % 3.6 %
Total 8.2 % 9.4 % 11.6 % -17.8 % 2.7 % 7.7 %

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6807550&lang=en

Acxiom Investor Relations

Katharine Boyce, 501-342-1321

investor.relations@acxiom.com

EACXM

Wednesday, July 27th, 2011 Uncategorized Comments Off on Acxiom (ACXM) Announces First Quarter Fiscal Year 2012 Results

FONAR (FONR) Announces UPRIGHT MRI Sale to Neuroscience Spine Institute in Northeast U.S

MELVILLE, NY — (Marketwire) — 07/27/11 — FONAR Corporation (NASDAQ: FONR), The Inventor of MR Scanning™, announced it has sold an UPRIGHT® Multi-Position™ MRI to a physician practice of radiologists and neurosurgeons. The UPRIGHT® MRI will be placed in a newly-constructed 50,000 sq. ft. building, increasing the practice to 75,000 sq. ft. for the new state-of-the-art neuroscience spine institute.

The group, who purchased the FONAR UPRIGHT® Multi-Position™ MRI, said they wanted the best diagnostic device available to allow them to be a “Center of Excellence” for spine care. Accordingly, they considered other state-of-the-art MRI scanners including those with field strengths at 3.0 and 1.5 Tesla, but those systems are single-position only and non-weight bearing. They therefore concluded that to be a “Center of Excellence for the Spine, it was crucial to have an MRI that could evaluate the spine in its full range of dynamic weight-bearing positions. A group representative said that essential in selecting the FONAR UPRIGHT® MRI was the unique, dynamic capabilities of UPRIGHT® MRI scanning vs. recumbent MRI scanning. He remarked, “The UPRIGHT® MRI’s ability to provide CSP™, or Correlated Slice Profile Imaging, shows how four images of the spine in all of its weight-bearing positions (flexion, extension, neutral sitting) and in the recumbent position significantly communicates the value of dynamic imaging.”

Raymond Damadian, M.D., president and founder of FONAR said, “Correlated Slice Profile (CSP)™ Imaging can be done for most spine patients. The patient having the spine scan is scanned in the four positions of Upright®-neutral, Upright®-flexion, Upright®-extension, and traditional recumbent. At the conclusion of the scan, the MRI technologist selects a center-slice saggital view from each of the four positions. The four image positions are then displayed side by side. In this way, one can quickly comprehend how a patient’s pathology changes from position to position within the same anatomic slice. This multi-position weight-bearing imaging of the spine enables the patient’s physician to see ALL of the patient’s symptom-generating pathology so they can be CORRECTLY addressed therapeutically or surgically (if necessary).”

An example follows: To see the example, please visit: http://www.fonar.com/news/072711.htm

As one begins to visualize the patient’s pathology, and moves from left to right, they will note the following:

Conventional Recumbent Position — minimal disc pathology, patent ventral spinal canal UPRIGHT® Sitting Neutral Position — anterior shift of spinal cord
UPRIGHT® Sitting Flexion Position — more marked anterior shift of spinal cord with interruption of CSF flow in the ventral spinal canal
UPRIGHT® Sitting Extension Position — disc herniations (C6/7 and C5/6) obstructing the ventral spinal canal and interrupting ventral canal CSF flow

Dr. Damadian continued, “Back Pain is a huge problem for Americans. Our normal vertical posture places undue strain on the 24 vertebra, 31 pairs of nerves, and 40 muscles of the spine.”

‘In 2005 Americans spent $85.9 billion looking for relief from back and neck pain through surgery, doctor’s visits, X-rays, MRI scans and medications, up from $52.1 billion in 1997, according to a study in the Feb. 13, (2005) issue of the Journal of the American Medical Association (JAMA). That money hasn’t helped reduce the number of sufferers; in 2005, 15 percent of U.S. adults reported back problems — up from 12 percent in 1997.’ (http://www.newsweek.com/2008/02/11/the-price-of-pain.html).

“A great problem in medicine is that of the failed back surgery syndrome (FBSS),” said Dr. Damadian. “The old diagnostic method of recumbent-only MRI is simply inadequate for correctly diagnosing problems of the spine. This group of spine professionals who just purchased the FONAR UPRIGHT® Multi-Position™ MRI recognizes that the spine is a long, fully integrated, physiologic organ where imbalances at one end can have pronounced consequences at the other end. Accordingly, only a fully dynamic image of the spine in its full range of weight-bearing positions can assess the patient’s symptom-generating spine pathology COMPLETELY. It is the only way an accurate diagnosis of the source of the patient’s spine symptoms can be achieved and a successful treatment accomplished. We are delighted with our new method of Correlated Slice Profile Imaging (CSP) and suggest that it will change the practice of medicine.”

About FONAR

FONAR was incorporated in 1978, making it the first, oldest and most experienced MRI company in the industry. FONAR introduced the world’s first commercial MRI in 1980, and went public in 1981. Since its inception, nearly 300 recumbent-OPEN MRIs and 150 UPRIGHT® Multi-Position™ MRI scanners have been installed worldwide. FONAR’s stellar product line includes the UPRIGHT® MRI (also known as the STAND-UP® MRI), the only whole-body MRI that performs Position™ imaging (pMRI™) and scans patients in numerous weight-bearing positions, i.e. standing, sitting, in flexion and extension, as well as the conventional lie-down position. The FONAR UPRIGHT® MRI often sees the patient’s problem that other scanners cannot because they are lie-down only. The patient-friendly UPRIGHT® MRI has a near zero claustrophobic rejection rate by patients. As a FONAR customer states, “If the patient is claustrophobic in this scanner, they’ll be claustrophobic in my parking lot.” Approximately 85% of patients are scanned sitting while they watch a 42″ flat screen TV. FONAR is headquartered on Long Island, New York.

For investor and other information visit: www.fonar.com.

UPRIGHT® and STAND-UP® are registered trademarks and The Inventor of MR Scanning™, Multi-Position™, pMRI™, Dynamic™, Full Range of Motion™, True Flow™, The Proof is in the Picture™, Spondylography™, Spondylometry™ Landscape™, CSP™ and Upright Radiology™ are trademarks of FONAR Corporation.

This release may include forward-looking statements from the company that may or may not materialize. Additional information on factors that could potentially affect the company’s financial results may be found in the company’s filings with the Securities and Exchange Commission.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=1684156

Contact:
Daniel Culver
FONAR Corporation
Tel: 631-694-2929
Fax: 631-390-1709
http://www.fonar.com
Email Contact

Wednesday, July 27th, 2011 Uncategorized Comments Off on FONAR (FONR) Announces UPRIGHT MRI Sale to Neuroscience Spine Institute in Northeast U.S

Marshall Edwards (MSHL) Announces Publication of Pre-Clinical Studies in Pancreatic Cancer

SAN DIEGO, June 27, 2011 /PRNewswire/ — Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel therapeutics targeting cancer metabolism, announced today the publication of results from pre-clinical studies of Triphendiol, a prodrug of the Company’s lead drug candidate NV-143, that demonstrate its anti-proliferative activity in pancreatic cancer as both a monotherapy and as a chemosensitizer. The publication is now available on the Anti-Cancer Drugs website and scheduled to print in the August issue of the journal.

The studies, conducted in collaboration with lead author Ewan Tytler, Ph.D., at the University of Alabama at Birmingham Medical Center and the Yale University School of Medicine, detail the in vitro activity of Triphendiol in pancreatic cancer cells as well as its in vivo activity in animal models of pancreatic cancer. In addition, both studies show that pre-treatment with Triphendiol enhances the cytotoxic effect of gemcitabine, the standard-of-care chemotherapy currently used to treat advanced pancreatic cancer. An abstract of the publication, entitled “Triphendiol (NV-196), Development of a Novel Therapy for Pancreatic Cancer,” can be found at www.marshalledwardsinc.com/our-programs/scientific-publications.

In previous laboratory studies, Triphendiol demonstrated anti-cancer activity against a broad range of tumor cell lines, including breast, colorectal and ovarian. Once administered, Triphendiol is converted in vivo into an active metabolite called NV-143. In addition to being more active than Triphendiol as a single agent, NV-143 appears to be superior in its ability to synergize with chemotherapy in pre-clinical studies. Marshall Edwards has completed the required pre-clinical studies of NV-143 necessary to complete an Investigational New Drug application, which it plans to submit to the U.S. Food and Drug Administration next month.

“These studies add to our growing collection of data regarding the activity of our compounds and their potential ability to enhance the effects of current treatments,” said Robert D. Mass, MD, Chief Medical Officer of Marshall Edwards. “These data further support the clinical development strategy for our lead candidate NV-143, the primary metabolite of Triphendiol, in combination with standard-of-care chemotherapy, while expanding the potential drug combinations we can consider in our randomized Phase II clinical trials.”

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company’s lead programs focus on two families of small molecules that result in the inhibition of tumor cell metabolism. The first and most advanced is a NADH oxidase inhibitor program that includes Triphendiol and lead drug candidate NV-143. The second is a mitochondrial inhibitor program that includes NV-128 and its next-generation candidate NV-344. Both programs are expected to advance into the clinic in 2011. For more information, please visit www.marshalledwardsinc.com.

Under U.S. law, a new drug cannot be marketed until it has been investigated in clinical trials and approved by the FDA as being safe and effective for the intended use. Statements included in this press release that are not historical in nature are “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. You should be aware that our actual results could differ materially from those contained in the forward-looking statements, which are based on management’s current expectations and are subject to a number of risks and uncertainties, including, but not limited to, our failure to successfully commercialize our product candidates; costs and delays in the development and/or FDA approval, or the failure to obtain such approval, of our product candidates; uncertainties or differences in interpretation in clinical trial results; our inability to maintain or enter into, and the risks resulting from our dependence upon, collaboration or contractual arrangements necessary for the development, manufacture, commercialization, marketing, sales and distribution of any products; competitive factors; our inability to protect our patents or proprietary rights and obtain necessary rights to third party patents and intellectual property to operate our business; our inability to operate our business without infringing the patents and proprietary rights of others; general economic conditions; the failure of any products to gain market acceptance; our inability to obtain any additional required financing; technological changes; government regulation; changes in industry practice; and one-time events. We do not intend to update any of these factors or to publicly announce the results of any revisions to these forward-looking statements.

SOURCE Marshall Edwards, Inc.

Wednesday, July 27th, 2011 Uncategorized Comments Off on Marshall Edwards (MSHL) Announces Publication of Pre-Clinical Studies in Pancreatic Cancer

Scorpex, Inc. (SRPX) Applauds US-Mexico Trucking Agreement

LAS VEGAS, NV–(Marketwire – July 21, 2011) – Scorpex, Inc. (PINKSHEETS: SRPX) (the “Company”), an emerging leader of industrial, hazardous and toxic waste disposal services in the Baja Mexico/California region, today praises the recent US-Mexican agreement allowing each country’s trucks to traverse the other’s highways. The agreement ends nearly two decades of quarreling between the two countries over a key provision of the 1994 NAFTA agreement.

As a result of the agreement, the high tariffs imposed by Mexico on dozens of U.S. products will be suspended when full cross-border traffic begins. Allowing long-haul trucking between the U.S. and Mexico is anticipated to create additional jobs and greater opportunity for both nations. The U.S. agriculture sector alone was negatively affected by these tariffs by an estimated $153 billion.

Chief Executive Officer Joseph Caywood stated, “I believe the lifting of these restrictions and tariffs carries significant weight for Scorpex. Not only does this agreement give Scorpex access to cross-border travel as necessary, it potentially feeds increased export, manufacturing and distribution in Mexico, subsequently driving the need for increased disposal of industrial waste.”

With its first facility located near Ensenada, Mexico, 85 miles from the U.S. border, Scorpex expects to be able to process 800 tons of waste per day once equipment is installed and the facility is fully operational. The demand for waste disposal in the Baja area is already much higher than that, ensuring steady demand and abundant prospects for future growth.

About Scorpex, Inc.

Scorpex, Inc. is taking the necessary steps to own and operate a full service waste disposal and recycling company, capable of storing and disposing all types of waste, including those classified as industrial, toxic, and hazardous. The location chosen for the first Scorpex plant is strategically positioned to accommodate the vast region of Baja California, Mexico.

For more information, visit www.scorpex.com

About MissionIR

MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. Through a full suite of investor relations and consultancy services, we help public companies develop and execute a strategic investor awareness plan as we’ve done for hundreds of others. Whether it is capital raising, increasing awareness among the financial community, or enhancing corporate communications, we offer a variety of solutions to meet the objectives of our clients.

For more information on Scorpex, Inc., visit http://SRPX.MissionIR.com

This press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Thursday, July 21st, 2011 Uncategorized Comments Off on Scorpex, Inc. (SRPX) Applauds US-Mexico Trucking Agreement

Uranerz (URZ) Receives Final NRC Approval

CASPER, WYOMING–(Marketwire – 07/20/11) – Uranerz Energy Corporation (“Uranerz” or the “Company”) (TSX:URZNews)(NYSE Amex:URZ)(FRANKFURT:U9ENews) is pleased to announce that the United States Nuclear Regulatory Commission (“NRC”) has issued the Materials License for the Company’s Nichols Ranch ISR Uranium Project located in the Central Powder River Basin of Wyoming, U.S.A. The Materials License is the last NRC authorization required to commence on-site construction for eventual production at the Nichols Ranch ISR Uranium Project.

Construction activities will commence within the next few days to take full advantage of the summer/fall construction season in Wyoming. Uranerz has already initiated procurement of ion exchange equipment, including three sand filters and six resin loading columns. Well-field installation equipment is also on order including a cement silo, cementing pressure pump units, mixing trucks and well casing. The local electric utility has recently completed construction of a substation in close proximity to the Nichols Ranch project which will service the Company’s mining operations in the Powder River Basin as well as other industrial projects in the region.

“The receipt of the NRC Materials License, the final step in the NRC licensing process, marks a very significant milestone achieved by the Company and represents the culmination of over four years of effort which was spearheaded by Mike Thomas our Manager of Environment, Health and Safety,” stated Uranerz CEO & President Glenn Catchpole. “I congratulate our entire staff for their valuable contributions through the permitting process. The hiring of new staff is now underway and the Company is focused on the development and planned operation of the Nichols Ranch ISR Uranium Project.”

To view the photo accompanying this release please click on the following link: http://media3.marketwire.com/docs/0720urz.jpg

About Uranerz

Uranerz Energy Corporation is a U.S.-based uranium company focused on achieving near-term commercial in-situ recovery (“ISR”) uranium production in Wyoming, the largest producer of uranium of any U.S. state. The Uranerz management team has specialized expertise in the ISR uranium mining method, and has a record of licensing, constructing, and operating commercial ISR uranium projects. The Company has already entered into long-term uranium sales contracts with two of the largest nuclear utilities in the U.S., including Exelon.

Uranerz Energy Corporation is listed on the NYSE Amex and the Toronto Stock Exchange under the symbol “URZ”, and listed on the Frankfurt Stock Exchange under the symbol “U9E”.

Further Information

For further information, please contact Derek Iwanaka, Manager of Investor Relations at 1-800-689-1659 or by email at info@uranerz.com. Alternatively, please refer to the Company’s website at www.uranerz.com, review the Company’s filings with the Securities and Exchange Commission at www.sec.gov, or visit the Company’s profile on SEDAR at www.sedar.com.

Forward-looking Statements

This press release may contain or refer to “forward-looking information” and “forward-looking statements” within the meaning of applicable United States and Canadian securities laws, which may include, but are not limited to, statements with respect to the anticipated timing and progress of construction commencement and equipment procurement, the anticipated availability of electricity, and all statements containing projections or plans or estimates or which predict or project the outcome of the Nichols Ranch ISR Uranium Project operations. Such forward-looking statements reflect our current views with respect to future events and are subject to certain risks, uncertainties and assumptions, including, the risks and uncertainties outlined in our most recent financial statements and reports and registration statement filed with the United States Securities and Exchange Commission (the “SEC”) (available at www.sec.gov) and with Canadian securities administrators (available at www.sedar.com). Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. We do not undertake to update forward-looking statements, except as required by law.

Wednesday, July 20th, 2011 Uncategorized Comments Off on Uranerz (URZ) Receives Final NRC Approval

Winn-Dixie’s (WINN) Food Recovery Program Provided Six Million Nutritious Meals in First Year

Jun. 20, 2011 (Business Wire) — Winn-Dixie Stores, Inc. (NASDAQ: WINN), announced today that the grocer provided approximately eight million pounds of perishable items – or more than six million nutritious meals – to the affiliate food banks of Feeding America, the nation’s leading domestic hunger-relief charity. Winn-Dixie first piloted its food recovery program in 10 stores beginning in January 2009 and expanded the program to all of its stores last April.

“Food banks continue to see requests for help from many families who are struggling to provide three square meals a day,” said Mary Kellmanson, group vice president of marketing for Winn-Dixie. “At Winn-Dixie, our goal is to be at the heart of our neighborhoods, and that’s why we created the food recovery program – to ease the stress on the food banks and to help provide better nutrition to families who need it the most.”

The grocer partners with local Feeding America affiliate food banks in Alabama, Georgia, Florida, Mississippi and Louisiana, donating perishable items that reach their ‘sell by’ date but are still usable and nutritious to feed the hungry. Donations of usable food by stores include bread, meats, cheeses, bagged fruits and vegetables, gelatin desserts, and sandwiches. Local Feeding America affiliate food banks visit the stores every few days to pick up the food donations, which are quickly distributed to after-school feeding programs, homeless shelters and food pantries.

“Feeding America is so grateful to Winn-Dixie for this generous donation of nutritious food through their Food Recovery Program,” said Vicki Escarra, president and CEO of Feeding America. “We are committed to securing nutritious food and groceries for the people we serve. Winn-Dixie’s contribution is tremendously important, especially during this time, when so many Americans are in need of emergency food assistance.”

One in six Americans struggles with hunger, including many children. Feeding America and its network of regional food banks is helping feed people in need. To find out how to help, go to http://feedingamerica.org/get-involved.aspx.

About Feeding America

Feeding America provides low-income individuals and families with the fuel to survive and even thrive. As the nation’s leading domestic hunger-relief charity, our network members supply food to more than 37 million Americans each year, including 14 million children and 3 million seniors. Serving the entire United States, more than 200 member food banks support 61,000 agencies that address hunger in all of its forms. For more information on how you can fight hunger in your community and across the country, visit http://www.feedingamerica.org. Find us on Facebook at facebook.com/FeedingAmerica or follow our news on Twitter at twitter.com/FeedingAmerica.

About Winn-Dixie

Winn-Dixie Stores, Inc., is one of the nation’s largest food retailers. Founded in 1925, the Company is headquartered in Jacksonville, Fla. The Company currently operates 484 retail grocery locations, including 379 in-store pharmacies, in Florida, Alabama, Louisiana, Georgia and Mississippi. For more information, please visit www.winn-dixie.com.

Winn-Dixie Stores, Inc.

Hunter Robinson, 904-783-5153

904-571-6052 (cell)

hunterrobinson@winn-dixie.com

or

St. John & Partners

Patrick McSweeney, 904-596-2085

904-923-4871 (cell)

patrickm@sjp.com

Wednesday, July 20th, 2011 Uncategorized Comments Off on Winn-Dixie’s (WINN) Food Recovery Program Provided Six Million Nutritious Meals in First Year

CTDC (CTDC) Reaffirms Commitment to Solar Projects Investment

HONG KONG, July 20, 2011 (GLOBE NEWSWIRE) — China Technology Development Group Corporation (Nasdaq:CTDC) (“CTDC” or the “Company”), a growing clean energy group that provides solar energy products and solutions, based in Hong Kong with sales offices in Milan and Munich, announced today that the Company has reaffirmed its commitment to solar projects investment and plans to file its interim report for 2011 with the SEC by the end of August.

“We are very pleased to have PricewaterhouseCoopers as our auditor for the past two years, which sets us apart from problematic companies in the China space,” Zhenwei Lu, Chief Financial Officer of CTDC, said. “We are gaining traction on the investment and construction of solar parks in Italy as our business model is geared towards providing equity and loans for PV projects.”

“Our current majority shareholders will not rule out the possibility of increasing their holdings of CTDC shares as a way of supporting our growth,” Alan Li, Chairman and CEO of CTDC, said.

About China Technology Development Group Corporation (Nasdaq:CTDC)

CTDC, a fast-growing clean energy group based in Hong Kong, provides solar energy products and solutions to the global market under the “LSP” brand.

For more information, please visit http://www.chinactdc.com

Forward-Looking Statement Disclosure:

It should be noted that certain statements herein which are not historical facts, including, without limitation, those regarding: A) the timing of product, service and solution deliveries; B) the Company’s ability to develop, implement and commercialize new products, services, solutions and technologies; C) expectations regarding market growth, developments and structural changes; D) expectations regarding the Company’s product volume growth, market share, prices and margins; E) expectations and targets for the Company’s results of operations; F) the outcome of pending and threatened litigation; G) expectations regarding the successful completion of contemplated acquisitions on a timely basis and the Company’s ability to achieve the set targets upon the completion of such acquisitions; and H) statements preceded by “believe,” “expect,” “anticipate,” “foresee,” “target,” “estimate,” “designed,” “plans,” “will” or similar expressions are forward-looking statements. These statements are based on management’s best assumptions and beliefs in light of the information currently available to it. Because they involve risks and uncertainties, actual results may differ materially from the results that the Company currently expect. Factors that could cause these differences include the risk factors specified on the Company’s annual report on Form 20-F for the year ended December 31, 2010 under “Item 3.D Risk Factors.” Other unknown or unpredictable factors or underlying assumptions subsequently proving to be incorrect could cause actual results to differ materially from those in the forward-looking statements. The Company does not undertake any obligation to update publicly or revise forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent legally required.

CONTACT: Weining Zhang, Chief Communications officer
         China Technology Development Group Corporation
         Tel:  +1 415 358 0899
         Email: ir@chinactdc.com
         Web: www.chinactdc.com
Wednesday, July 20th, 2011 Uncategorized Comments Off on CTDC (CTDC) Reaffirms Commitment to Solar Projects Investment

Bacterin (BONE) Expects Q2 2011 Revenue up 134% to Record $7.5 Million

BELGRADE, Mont., July 18, 2011 /PRNewswire/ — Bacterin International Holdings, Inc. (NYSE Amex: BONE), a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.

Based on preliminary unaudited information, the company expects to report Q2 2011 revenue of approximately $7.5 million, representing an increase of 25% from $6.0 million in the previous quarter, and up 134% from $3.2 million in the same year-ago quarter.

The revenue increase is attributed to continued growth in the number of domestic hospitals and new international accounts using Bacterin products, as driven by the company’s expanding direct and outside sales force.

“Our record revenue reflects the tremendous operational progress we made during the quarter,” said Guy Cook, the company’s chairman and CEO. “This included the launch of our third human acellular biological scaffold during the quarter, hMatrix, which has opened the door to a $2.5 billion market in the U.S. alone.

“We expect this revenue momentum and domestic and international market expansion to continue building throughout the rest of the year, especially with the recent addition of Bacterin’s product line to ROI’s nationwide network of hospitals and medical practices,” said Cook. “We also plan to leverage our direct sales force with new product lines that complement existing ones.”

The company’s successful capital raise during the quarter has increased working capital for continued product development, including enhancing the newly acquired Robinson MedSurg orthopedic implants with Bacterin’s anti-microbial coating technology. Bacterin is pursuing the FDA market approval process to add its anti-microbial coatings to the RMS product line, and plans to submit a 510(k) application before the end of the year.

Bacterin’s management plans to hold a conference call in the second week of August to discuss the second quarter and will announce the details of the call approximately two weeks prior. These preliminary results are subject to a final auditor’s review and filing of its quarterly report in Form 10-Q.

About Bacterin International Holdings

Bacterin International Holdings, Inc. (NYSE Amex: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin’s proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral repair in knee and other joint surgeries.

Bacterin’s Medical Device division develops, employs, and licenses bioactive coatings for various medical device applications. Bacterin’s strategic coating initiatives include antimicrobial coatings designed to inhibit biofilm formation and microbial contamination. For further information, please visit www.bacterin.com.

Important Cautions Regarding Forward-looking Statements

This news release contains certain disclosures that may be deemed forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to significant risks and uncertainties. Forward-looking statements include statements that are predictive in nature, that depend upon or refer to future events or conditions, or that include words such as “continue,” “efforts,” “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “projects,” “forecasts,” “strategy,” “will,” “goal,” “target,” “prospects,” “potential,” “optimistic,” “confident,” “likely,” “probable” or similar expressions or the negative thereof. Statements of historical fact also may be deemed to be forward-looking statements. We caution that these statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others: the Company’s ability to meet its obligations under existing and anticipated contractual obligations; the Company’s ability to develop, market, sell and distribute desirable applications, products and services and to protect its intellectual property; the ability and willingness of third-party manufacturers to timely and cost-effectively fulfill orders from the Company; the ability of the Company’s customers to pay and the timeliness of such payments, particularly during recessionary periods; the Company’s ability to obtain financing as and when needed; changes in consumer demands and preferences; the Company’s ability to attract and retain management and employees with appropriate skills and expertise; the impact of changes in market, legal and regulatory conditions and in the applicable business environment, including actions of competitors; and other factors. The Company undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Investor Relations:
Liolios Group, Inc.
Scott Liolios or Ron Both
Tel 949-574-3860
info@liolios.com

Monday, July 18th, 2011 Uncategorized Comments Off on Bacterin (BONE) Expects Q2 2011 Revenue up 134% to Record $7.5 Million

Check Point Software Technologies (CHKP) Reports Record 2011 Second Quarter Financial Results

REDWOOD CITY, CA — (Marketwire) — 07/18/11 — Check Point® Software Technologies Ltd. (NASDAQ: CHKP)

  • Total Revenue: $300.6 million, representing a 15 percent increase year over year
  • Non-GAAP Operating Income: $171.0 million, representing 57 percent of revenues
  • Non-GAAP EPS: $0.68, representing a 17 percent increase year over year

Check Point® Software Technologies Ltd. (NASDAQ: CHKP), the worldwide leader in securing the Internet, today announced its financial results for the second quarter ending June 30, 2011.

“The first half of 2011 produced great results. We continued to outperform our projections in the second quarter. These good results are driven by increased sales of enterprise gateways with more software blades attached. In particular, our IPS and Application Control software blades have shown significant growth in the second quarter,” said Gil Shwed, founder, chairman, and chief executive officer of Check Point Software Technologies.

Financial Highlights:

  • Total Revenue: $300.6 million, an increase of 15 percent, compared to $261.1 million in the second quarter of 2010.
  • GAAP Operating Income: $150.0 million, an increase of 23 percent, compared to $122.1 million in the second quarter of 2010. GAAP operating margin was 50 percent, compared to 47 percent in the second quarter of 2010.
  • Non-GAAP Operating Income: $171.0 million, an increase of 18 percent, compared to $144.7 million in the second quarter of 2010. Non-GAAP operating margin was 57 percent, compared to 55 percent in the second quarter of 2010.
  • GAAP Net Income and Earnings per Diluted Share: GAAP net income was $128.0 million, an increase of 24 percent, compared to $102.9 million in the second quarter of 2010. GAAP earnings per diluted share were $0.60, an increase of 25 percent, compared to $0.48 in the second quarter of 2010.
  • Non-GAAP Net Income and Earnings per Diluted Share: Non-GAAP net income was $145.5 million, an increase of 19 percent, compared to $122.4 million in the second quarter of 2010. Non-GAAP earnings per diluted share were $0.68, an increase of 17 percent, compared to $0.58 in the second quarter of 2010.
  • Deferred Revenues: As of June 30, 2011, the company had deferred revenues of $457.0 million, an increase of 10 percent, compared to $414.8 million as of June 30, 2010.
  • Cash Flow: Cash flow from operations was $175.5 million, an increase of 18 percent, compared to $148.9 million in the second quarter of 2010.
  • Share Repurchase Program: During the second quarter of 2011, the company repurchased 1.38 million shares at a total cost of $75 million.
  • Cash Balances, Marketable Securities and Short Term Deposits: $2,689.8 million as of June 30, 2011, an increase of $548.9 million, compared to $2,140.9 million as of June 30, 2010.

For information regarding the Non-GAAP financial measures discussed in this release, please see “Use of Non-GAAP Financial Information” and “Reconciliation of GAAP to Non-GAAP Financial Information.”

Business Highlights:
Check Point has continued to deliver advanced and award-winning solutions that have earned the trust of customers from around the world. The success of this quarter continues to validate the company’s product innovation and continued growth as a pure-play security company. In addition, significant recent developments in Check Point’s business include the introduction of new products and the promotion of an officer:

  • ZoneAlarm SocialGuard – Enables parents to protect their children against social threats on Facebook, such as online predators, cyberbullies, hacked accounts and malicious links. The product has received “Five Stars” from CNET and a “Highly Recommended” rating from PC Magazine.
  • ZoneAlarm 2012 Suite – Features new cloud-enabled security with parental controls and advanced antivirus capabilities that utilize ZoneAlarm DefenseNet™, a cloud-based service that detects over 50,000 new applications and threats daily, to silently stop existing and emerging attacks.
  • Promotion of Amnon Bar-Lev, Head of Global Field Operations to President – Check Point announced today that Amnon Bar-Lev has been promoted to President of Check Point Software Technologies, effective immediately. Amnon joined Check Point in 2005 and has led the company’s field organization since 2006. During that period, Check Point’s revenues have more than doubled to approximately $1.2B over the past four quarters. Amnon will continue to head the company’s customer facing functions including sales, marketing, business development and technical services. He will continue to report to Gil Shwed, founder, chairman and CEO.

Recent Industry Accolades From Across the Globe:

  • NSS Labs Group Firewall Test – Check Point was the only vendor to pass the NSS Labs independent Firewall Group Test, achieving 100 percent in security effectiveness and earning the only “Recommend” rating in the initial comparative review.
  • Frost & Sullivan Asia Pacific – Check Point was recognized by the industry analyst firm as the 2011 Network Security Vendor of the Year.
  • Association of Support Professionals – Check Point was a winner of the “Top Ten Best Web Support Sites of 2011” for a third year.
  • SC Magazine UK, Best Secure Virtualization Solution – Check Point Security Gateway VE.
  • Computerworld Czech Republic, IT Product of 2011 – Check Point Application Control Software Blade.
  • Computerworld Hong Kong Awards – Named best UTM, Firewall/VPN and Intrusion Prevention solutions.
  • Electronic Times, 2011 Hit Products in Korea – Check Point Application Control Software Blade.
  • Computerworld Singapore, Customer Care Awards – Check Point Firewall/VPN.

In addition, Check Point’s founder, chairman and CEO, Gil Shwed, along with Tal Payne, CFO, and the company’s board of directors, rang the NASDAQ opening bell on June 28, 2011, commemorating the company’s fifteenth anniversary since its initial public offering in 1996.

Shwed concluded, “Our security focus is continuing to pay off. I’m pleased to see that customers are adopting more software blades to enhance their threat protection and raise the level of security in their organization. We will continue to deliver on our 3D security vision combining policy, people and enforcement to provide the best protection for our customers.”

Third Quarter Investor Conference Participation Schedule:

  • Pacific Crest Internet, Media and Telecommunications Conference
    August 8, 2011 – Vail, CO
  • Citi Global Technology, Media and Telecommunications Conference
    September 8, 2011 – NY, NY
  • Deutsche Bank Technology, Media and Telecommunications Conference
    September 14, 2011 – Las Vegas, NV

Members of Check Point’s management team will present at these conferences and discuss the latest company strategies and initiatives. Check Point’s conference presentations are expected to be available via webcast on the company’s web site. To view these presentations and access the most updated information please visit the company’s web site at www.checkpoint.com/ir . The schedule is subject to change.

Conference Call and Webcast Information
Check Point will host a conference call with the investment community on July 18, 2011 at 8:30 AM ET/5:30 AM PT. To listen to the live webcast, please visit Check Point’s website at: www.checkpoint.com/ir. A replay of the conference call will be available through July 25, 2011 at the company’s website www.checkpoint.com/ir or by telephone at +1.201.612.7415, replay ID number 375092, account # 215.

About Check Point Software Technologies Ltd.
Check Point Software Technologies Ltd. (www.checkpoint.com), the worldwide leader in securing the Internet, is the only vendor to deliver Total Security for networks, data and endpoints, unified under a single management framework. Check Point provides customers with uncompromised protection against all types of threats, reduces security complexity and lowers total cost of ownership. Check Point first pioneered the industry with FireWall-1 and its patented stateful inspection technology. Today, Check Point continues to innovate with the development of the Software Blade Architecture™. The dynamic Software Blade Architecture delivers secure, flexible and simple solutions that can be fully customized to meet the exact security needs of any organization or environment. Check Point customers include tens of thousands of businesses and organizations of all sizes including all Fortune 100 companies. Check Point’s award-winning ZoneAlarm solutions protect millions of consumers from hackers, spyware and identity theft.

©2011 Check Point Software Technologies Ltd. All rights reserved

Use of Non-GAAP Financial Information
In addition to reporting financial results in accordance with generally accepted accounting principles, or GAAP, Check Point uses non-GAAP measures of net income, operating income, operating margin and earnings per share, which are adjustments from results based on GAAP to exclude non-cash equity-based compensation charges, amortization of acquired intangible assets, restructuring and other acquisitions related costs, gain on sale of marketable securities previously impaired, and the related tax affects. Check Point’s management believes the non-GAAP financial information provided in this release is useful to investors’ understanding and assessment of Check Point’s ongoing core operations and prospects for the future. Historically, Check Point has also publicly presented these supplemental non-GAAP financial measures in order to assist the investment community to see the Company “through the eyes of management,” and thereby enhance understanding of its operating performance. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for results prepared in accordance with GAAP. A reconciliation of the non-GAAP financial measures discussed in this press release to the most directly comparable GAAP financial measures is included with the financial statements contained in this press release. Management uses both GAAP and non-GAAP information in evaluating and operating business internally and as such has determined that it is important to provide this information to investors.

                   CHECK POINT SOFTWARE TECHNOLOGIES LTD.
                 CONDENSED CONSOLIDATED STATEMENT OF INCOME

                   (In thousands, except per share amounts)

                             Three Months Ended         Six Months Ended
                         ------------------------- -------------------------
                                  June 30,                  June 30,
                         ------------------------- -------------------------
                             2011         2010         2011         2010
                         ------------ ------------ ------------ ------------
                          (unaudited)  (unaudited)  (unaudited)  (unaudited)
Revenues:
  Products and licenses  $    119,288 $    103,904 $    224,546 $    194,942
  Software updates,
   maintenance and
   subscription               181,356      157,187      357,372      311,226
                         ------------ ------------ ------------ ------------
Total revenues                300,644      261,091      581,918      506,168
                         ------------ ------------ ------------ ------------

Operating expenses:
  Cost of products and
   licenses                    18,983       16,287       36,635       32,792
  Cost of Software
   updates, maintenance
   and subscription            15,623       13,547       29,920       25,792
  Amortization of
   technology                   7,850        8,150       15,699       16,216
                         ------------ ------------ ------------ ------------
Total cost of revenues         42,456       37,984       82,254       74,800

  Research and
   development                 27,524       25,807       55,167       50,129
  Selling and marketing        64,785       58,619      123,294      113,395
  General and
   administrative              15,833       15,980       29,823       29,282
  Restructuring and
   other acquisitions
   related costs                    -          588            -          588
                         ------------ ------------ ------------ ------------
Total operating expenses      150,598      138,978      290,538      268,194
                         ------------ ------------ ------------ ------------

Operating income              150,046      122,113      291,380      237,974
Financial income, net          10,832        7,133       21,360       14,326
                         ------------ ------------ ------------ ------------
Income before taxes on
 income                       160,878      129,246      312,740      252,300
Taxes on income                32,887       26,385       62,659       51,398
                         ------------ ------------ ------------ ------------
Net income               $    127,991 $    102,861 $    250,081 $    200,902
                         ============ ============ ============ ============

Earnings per share
 (basic)                 $       0.62 $       0.49 $       1.20 $       0.96
                         ============ ============ ============ ============
Number of shares used in
 computing earnings per
 share (basic)                207,129      207,914      207,650      208,449
                         ============ ============ ============ ============

Earnings per share
 (diluted)               $       0.60 $       0.48 $       1.16 $       0.95
                         ============ ============ ============ ============
Number of shares used in
 computing earnings per
 share (diluted)              214,565      212,166      215,240      210,639
                         ============ ============ ============ ============

                   CHECK POINT SOFTWARE TECHNOLOGIES LTD.
          RECONCILIATION OF GAAP TO NON GAAP FINANCIAL INFORMATION

                  (In thousands, except per share amounts)

                         ------------------------  ------------------------
                            Three Months Ended         Six Months Ended
                         ------------------------  ------------------------
                                 June 30,                  June 30,
                         ------------------------  ------------------------
                             2011         2010         2011         2010
                         -----------  -----------  -----------  -----------
                         (unaudited)  (unaudited)  (unaudited)  (unaudited)

GAAP operating income    $   150,046  $   122,113  $   291,380  $   237,974
Stock-based compensation
 (1)                           9,900        9,080       18,145       18,013

Amortization of
 intangible assets (2)        11,032       12,893       22,063       25,656
Restructuring and other
 acquisitions related
 costs (3)                         -          588            -          588
                         -----------  -----------  -----------  -----------
Non-GAAP operating
 income                  $   170,978  $   144,674  $   331,588  $   282,231
                         ===========  ===========  ===========  ===========

GAAP net income          $   127,991  $   102,861  $   250,081  $   200,902
Stock-based compensation
 (1)                           9,900        9,080       18,145       18,013
Amortization of
 intangible assets (2)        11,032       12,893       22,063       25,656
Restructuring and other
 acquisitions related
 costs (3)                         -          588            -          588
Gain on Sale of
 marketable securities
 previously impaired(4)         (649)           -       (2,017)           -
Taxes on the above items
 (5)                          (2,759)      (3,025)      (5,688)      (5,973)
                         -----------  -----------  -----------  -----------
Non-GAAP net income      $   145,515  $   122,397  $   282,584  $   239,186
                         ===========  ===========  ===========  ===========

GAAP Earnings per share
 (diluted)               $      0.60  $      0.48  $      1.16  $      0.95
Stock-based compensation
 (1)                            0.04         0.05         0.08         0.10
Amortization of
 intangible assets (2)          0.05         0.06         0.10         0.12
Restructuring and other
 acquisitions related
 costs (3)                         -         0.00            -         0.00
Gain on Sale of
 marketable securities
 previously impaired(4)        (0.00)           -        (0.01)           -
Taxes on the above items
 (4)                           (0.01)       (0.01)       (0.02)       (0.03)
                         -----------  -----------  -----------  -----------
Non-GAAP Earnings per
 share (diluted)         $      0.68  $      0.58  $      1.31  $      1.14
                         ===========  ===========  ===========  ===========

Number of shares used in
 computing Non-GAAP
 earnings per share
 (diluted)                   214,565      212,166      215,240      210,639
                         ===========  ===========  ===========  ===========

(1) Stock-based
 compensation:
  Cost of products and
   licenses              $        19  $        17  $        30  $        28
  Cost of software
   updates, maintenance
   and subscription              255          231          445          458
  Research and
   development                 2,022        1,693        3,455        3,341
  Selling and marketing        1,690        1,550        3,581        3,796
  General and
   administrative              5,914        5,589       10,634       10,390
                         -----------  -----------  -----------  -----------
                         $     9,900        9,080  $    18,145       18,013
                         -----------  -----------  -----------  -----------

(2) Amortization of
 intangible assets:
  Amortization of
   technology-cost of
   revenues                    7,850        8,150       15,699       16,216
  Research and
   development                     -          685            -        1,370
  Selling and marketing        3,182        4,058        6,364        8,070
                         -----------  -----------  -----------  -----------
                              11,032       12,893       22,063       25,656
                         -----------  -----------  -----------  -----------

(3) Restructuring and
 other acquisitions
 related costs                     -          588            -          588
                         -----------  -----------  -----------  -----------

(4) Gain on Sale of
 marketable securities
 previously impaired            (649)           -       (2,017)           -
                         -----------  -----------  -----------  -----------

(5) Taxes on the above
 items                        (2,759)      (3,025)      (5,688)      (5,973)
                         -----------  -----------  -----------  -----------

Total, net               $    17,524  $    19,536  $    32,503  $    38,284
                         ===========  ===========  ===========  ===========

                   CHECK POINT SOFTWARE TECHNOLOGIES LTD.
                 CONDENSED CONSOLIDATED BALANCE SHEET DATA
                               (In thousands)
                                   ASSETS
                                                   June 30,    December 31,
                                                     2011          2010
                                                 ------------  ------------
                                                  (unaudited)    (audited)
Current assets:
Cash and cash equivalents                        $    359,018  $    551,777
Marketable securities and short-term deposits         791,517       537,718

Trade receivables, net                                197,168       283,192
Prepaid expenses and other current assets              52,042        44,247
                                                 ------------  ------------
Total current assets                                1,399,745     1,416,934
                                                 ------------  ------------

Long-term assets:
Marketable securities                               1,539,273     1,325,451
Property and equipment, net                            36,996        37,065
Severance pay fund                                      6,965         6,532
Deferred tax asset, net                                20,580        18,122
Other intangible assets, net                           44,701        66,765
Goodwill                                              717,052       717,052
Other assets                                           15,827        17,381
                                                 ------------  ------------
Total long-term assets                              2,381,394     2,188,368
                                                 ------------  ------------

Total assets                                     $  3,781,139  $  3,605,302
                                                 ============  ============

                              LIABILITIES AND
                            SHAREHOLDERS' EQUITY

Current liabilities:
Deferred revenues                                $    413,422  $    424,158
Trade payables and other accrued liabilities          223,480       239,104
                                                 ------------  ------------
Total current liabilities                             636,902       663,262
                                                 ------------  ------------

Long-term deferred revenues                            43,545        40,394
Income tax accrual                                    208,762       169,370
Deferred tax liability, net                             1,215         1,721
Accrued severance pay                                  12,179        11,224
                                                 ------------  ------------
                                                      265,701       222,709

                                                 ------------  ------------
Total liabilities                                     902,603       885,971
                                                 ------------  ------------

Shareholders' equity:
Share capital                                             774           774
Additional paid-in capital                            612,060       580,276
Treasury shares at cost                            (1,431,820)   (1,306,382)
Accumulated other comprehensive income                 18,362        15,584
Retained earnings                                   3,679,160     3,429,079
                                                 ------------  ------------
Total shareholders' equity                          2,878,536     2,719,331
                                                 ------------  ------------
Total liabilities and shareholders' equity       $  3,781,139  $  3,605,302
                                                 ============  ============

  Total cash and cash equivalents, marketable
   securities and short-term deposits            $  2,689,808  $  2,414,946
                                                 ============  ============

                   CHECK POINT SOFTWARE TECHNOLOGIES LTD.
                    SELECTED CONSOLIDATED CASH FLOW DATA
                               (In thousands)

                            Three Months Ended         Six Months Ended
                         ------------------------  ------------------------
                                 June 30,                  June 30,
                         ------------------------  ------------------------
                             2011         2010         2011         2010
                         -----------  -----------  -----------  -----------
                         (unaudited)  (unaudited)  (unaudited)  (unaudited)
Cash flow from operating
 activities:
Net income               $   127,991  $   102,861  $   250,081  $   200,902
Adjustments to reconcile
 net income to net cash
 provided by operating
 activities:
Depreciation and
 amortization of
 property, plant and
 equipment                     1,824        1,734        3,553        3,575
Decrease (increase) in
 trade and other
 receivables, net             (3,319)      23,610       79,906      123,653

Increase in deferred
 revenues, trade
 payables and other
 accrued liabilities          35,622        1,740       21,764        2,149
Realized gain on
 marketable securities        (2,481)           -       (2,481)           -
Stock-based compensation       9,900        9,080       18,145       18,013
Amortization of
 intangible assets            11,032       12,893       22,063       25,656
Excess tax benefit from
 stock-based
 compensation                 (2,035)      (1,127)      (2,088)      (2,960)
Deferred income taxes,
 net                          (3,025)      (1,857)      (3,829)      (4,249)
                         -----------  -----------  -----------  -----------
Net cash provided by
 operating activities        175,509      148,934      387,114      366,739
                         -----------  -----------  -----------  -----------

Cash flow from investing
 activities:

Cash paid in conjunction
 with acquisitions, net
 of acquired cash               (985)     (13,624)      (6,501)     (13,624)
Investment in property
 and equipment                (1,623)      (1,248)      (3,484)      (2,144)
                         -----------  -----------  -----------  -----------
Net cash used in
 investing activities         (2,608)     (14,872)      (9,985)     (15,768)
                         -----------  -----------  -----------  -----------

Cash flow from financing
 activities:
Proceeds from issuance
 of shares upon exercise
 of options                    8,036        1,938       39,551       33,998
Purchase of treasury
 shares                      (75,000)     (50,000)    (150,000)    (100,000)
Excess tax benefit from
 stock-based
 compensation                  2,035        1,127        2,088        2,960
                         -----------  -----------  -----------  -----------
Net cash used in
 financing activities        (64,929)     (46,935)    (108,361)     (63,042)
                         -----------  -----------  -----------  -----------

Unrealized gain on
 marketable securities,
 net                           9,633        2,051        6,094        5,988
                         -----------  -----------  -----------  -----------

Increase in cash and
 cash equivalents,
 marketable securities
 and short term deposits     117,605       89,178      274,862      293,917

Cash and cash
 equivalents, marketable
 securities and short
 term deposits at the
 beginning of the period   2,572,203    2,051,738    2,414,946    1,846,999
                         -----------  -----------  -----------  -----------

Cash and cash
 equivalents, marketable
 securities and short
 term deposits at the
 end of the period       $ 2,689,808  $ 2,140,916  $ 2,689,808  $ 2,140,916
                         ===========  ===========  ===========  ===========
Monday, July 18th, 2011 Uncategorized Comments Off on Check Point Software Technologies (CHKP) Reports Record 2011 Second Quarter Financial Results

Scorpex (SRPX) Receives Authorization From the Mexican Environmental Authority (PROFEPA) to Obtain Use and Operational Permits

LAS VEGAS, NV — (Marketwire) — 07/18/11 — Scorpex, Inc. (PINKSHEETS: SRPX) (the “Company”) today announces that PROFEPA, the agency in Mexico responsible for monitoring and enforcing environmental laws, has granted clearance to the Company for obtaining “Use” and “Operational” permits. Many of the employees of the environmental protection agency have visited and inspected the site numerous times and participated in the studies pertaining to the project.

Use permits from federal, state, and city governments, in addition to a federal operational permit, are necessary for the operation of a full service waste disposal and recycling company. To obtain these permits, the Company has complied with all governmental regulatory guidelines and directives, conducted feasibility studies, and worked hand-in-hand with government officials on key issues pertaining to zoning, road studies, environmental guidelines, land and health issues, as well as employment issues.

Joseph Caywood, Chief Executive Officer of Scorpex, stated, “Over the past several years, Scorpex has overcome numerous hurdles in order to meet the stringent requirements of Mexico. This most recent approval gives the Company a positive recommendation and the assurance that it has complied with and passed all required testing and studies as well as the requirements for the planned and presently completed property infrastructure, build outs and improvements.”

In conclusion, Mr. Caywood stated, “The Company is now poised to receive use and operational permits after carefully complying with all of the requests from the federal, state, and municipal governments to date. We are very pleased with the progress we are making towards the establishment of our first fully operational facility and the execution of our business plan.”

About Scorpex, Inc.
Scorpex, Inc. is taking the necessary steps to own and operate a full service waste disposal and recycling company, capable of storing and disposing all types of waste, including those classified as industrial, toxic, and hazardous. The location chosen for the first Scorpex plant is strategically positioned to accommodate the vast region of Baja California, Mexico.

For more information, visit www.scorpex.com

About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. Through a full suite of investor relations and consultancy services, we help public companies develop and execute a strategic investor awareness plan as we’ve done for hundreds of others. Whether it is capital raising, increasing awareness among the financial community, or enhancing corporate communications, we offer a variety of solutions to meet the objectives of our clients.

For more information on Scorpex, Inc., visit http://SRPX.MissionIR.com

This press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Contact:

Investor Relations
J.R. Munoz
310-891-1838

Monday, July 18th, 2011 Uncategorized Comments Off on Scorpex (SRPX) Receives Authorization From the Mexican Environmental Authority (PROFEPA) to Obtain Use and Operational Permits

PPD, Inc. (PPDI) Comments on Recent Stock Market Developments

WILMINGTON, N.C.–(BUSINESS WIRE)– Following recent stock market developments, PPD, Inc. (Nasdaq:PPDI) today announced that its board of directors has asked management to review PPD’s strategic plan and capital structure with a focus on unlocking value for shareholders.

“While the company generally has a policy of not commenting on speculation,” said Fred Eshelman, executive chairman of PPD, “we want to assure our customers and employees that the company remains focused on executing its long-term business strategy.” Eshelman added, “We are absolutely dedicated to performing for our customers and committed to executing the important research programs that they have entrusted to us.”

Eshelman continued, “We are looking at our long-term plan and our capital structure to see if there are any actions, which might create value at this time. We are not engaged in any discussions around a combination with other clinical research providers. We remain laser-focused on executing our business and serving our customers with the quality and service they expect and deserve.”

About PPD

PPD is a leading global contract research organization providing drug discovery, development and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 44 countries and more than 11,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments. For more information, visit www.ppdi.com.

Except for historical information, all of the statements, expectations and assumptions, including statements, expectations and assumptions relating to PPD’s strategic plan and capital structure, contained in this news release are forward-looking statements that involve a number of risks and uncertainties. Although PPD attempts to be accurate in making these forward-looking statements, it is possible that future circumstances might differ from the assumptions on which such statements are based and could cause actual results to differ materially from the forward-looking statements. Other important factors which could cause future results to differ materially include the following: economic conditions, R&D spending levels and outsourcing trends in the pharmaceutical, biotechnology and government-sponsored research sectors; overall global economic conditions; competition in the outsourcing industry; PPD’s ability to win new business; the rate of conversion of backlog into revenue; loss, delay or modification of large contracts; higher-than-expected cancellation rates; actual operating performance; fluctuations in currency exchange rates; risks associated with and dependence on strategic relationships; our ability to implement and risks associated with stock repurchases; rapid technological advances that make our services less competitive; risks associated with acquisitions and investments, such as impairments and integration, including PPD’s investment in Celtic Therapeutics; the ability to attract, integrate and retain key personnel, including a new CEO; our ability to control SG&A spending; risks associated with fixed price contracts and cost overruns; consolidation in the pharmaceutical and biotechnology industries; and risks that we may increase, reduce or discontinue our dividend policy. These and other PPD risk factors are set forth in more detail from time to time in our SEC filings, copies of which are available free of charge upon request from PPD’s investor relations department. PPD assumes no obligation and expressly disclaims any duty to update these forward-looking statements in the future, except as required by applicable securities laws. These forward-looking statements should not be relied upon as representing PPD’s estimates or views as of any date subsequent to the date hereof.

Monday, July 18th, 2011 Uncategorized Comments Off on PPD, Inc. (PPDI) Comments on Recent Stock Market Developments

Valence Technology (VLNC) Announces Preliminary Fiscal First Quarter 2012 Results

AUSTIN, Texas–(BUSINESS WIRE)– Valence Technology, Inc. (NASDAQ:VLNC), a leading U.S. based global manufacturer of advanced energy storage solutions, today announced that it expects revenue of approximately $13.5 to $14.0 million for its fiscal 2012 first quarter ended June 30, 2011.

Executive Commentary

“Our first quarter revenue is projected to be above our May 25, 2011 guidance of $8.5 to $10.5 million, principally due to significant shipments to Smith Electric Vehicles. In addition, we continue to see a positive trend in orders from both existing and new customers. This includes dozens of customers in diverse markets worldwide,” commented president and chief executive officer Robert L. Kanode.

“We believe our products’ performance, safety, durability, cycle life, and energy density offer a compelling solution. With five years of on-the-road experience and a family of standard and custom products, Valence is well positioned in pursuing a broad base of emerging worldwide markets. In addition, due to our experience and vertical integration Valence can quickly scale as markets mature and grow,” continued Kanode.

Key Highlights

  • In excess of 150 megawatt-hours of advanced energy storage solutions have been shipped since 2005.
  • 54 unique customers during fiscal Q1 2012 including corporations in the United States, United Kingdom, France, Canada, Italy, the Netherlands, and Spain.
  • Applications served include: metropolitan transit buses, sailboats, off-grid power trailers, postal scooters, commercial delivery vehicles, and Segway® personal transporters.

Quarterly Financial Results and Conference Call

No conference call will be held in conjunction with this news release. However, on August 3, 2011, Valence will release its first quarter financial results after the market closes, and Company management will conduct a conference call that day at 3:30 p.m. CT (4:30 p.m. ET) to discuss the results. Conference call details were announced in a press release issued July 13, 2011.

About Valence Technology, Inc.

Valence Technology is a global leader in the development and manufacture of safe, long-life lithium iron magnesium phosphate advanced energy storage solutions and integrated command and control logic. Headquartered in Austin, Texas, Valence enables and powers some of the world’s most innovative and environmentally friendly applications, ranging from commercial electric vehicles to industrial and marine equipment. Valence Technology today offers a proven technology and manufacturing infrastructure that delivers ISO-certified products and processes that are protected by an extensive global patent portfolio. In addition to the corporate headquarters in Texas, Valence Technology has its Research & Development Center in Nevada, its Europe/Asia Pacific Sales office in Northern Ireland and global fulfillment centers in North America and Europe. Valence Technology is traded on the NASDAQ Capital Market under the ticker symbol “VLNC.” For more information, visit www.valence.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among other things, our statements regarding our preliminary revenue for the first quarter of fiscal 2012, positive trend in orders from both existing and new customers, product performance, durability, cycle life, and energy density, being well positioned in pursuing worldwide markets and that Valence can quickly scale as markets mature and grow. Our actual results could vary substantially from these forward-looking statements as a result of a variety of factors including: the impact of our limited financial resources on our ability to execute on our business plan, commercially exploit our technology, respond to unanticipated developments and compete effectively in the marketplace, and that our current equity financing arrangements may not be sufficient to meet our cash requirements and the need to raise additional debt or equity financing to continue as a going concern and/or achieve our corporate goals; our uninterrupted history of quarterly losses and our ability to ever achieve profitability; our ability to meet the continued listing requirements of the NASDAQ Capital Market, particularly the $1 minimum bid price requirements; the overall demand for batteries to power electric vehicles, and the demand for our lithium-ion batteries and lithium phosphate battery technology; our ability to service our debt, which is substantial in relationship to our assets and equity values; the pledge of all of our assets as security for our existing indebtedness; our ability to protect and enforce our current and future intellectual property; the rate of customer acceptance and sales of our current and future products; our ability to form effective arrangements with OEMs to commercialize our products; the level and pace of expansion of our manufacturing capabilities, including our ability to scale our manufacturing and quality processes at a level necessary to support potential demand; product or quality defects; the level of direct costs and our ability to grow revenues to a level necessary to achieve profitable operating margins to achieve break-even cash flow; our dependence on sole or a limited number of suppliers for key raw materials and components, and the ability of our vendors to provide conforming materials for our products on a timely basis; the level of our selling, general and administrative costs; any impairment in the carrying value of our intangible or other assets; and our ability to achieve our intended strategic and operating goals; international business risks, particularly the many risks inherent in doing business in China; our ability to attract and retain key personnel; the failure to expand our customer base particularly in light of our current dependence on a small number of customers for our revenues; the effects of competition; the outcome of any current or future litigation regarding intellectual property or other matters and general economic conditions, including a decrease in demand for our products which may be related to a sustained decrease in the price of oil, and the potential for reduced overall demand for vehicles or other applications that use our products and technology due to reduced global demand or economic downturn. These and other risk factors that could affect our actual results are discussed in our periodic reports filed with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended March 31 and subsequent Quarterly Reports on Form 10-Q and other documents filed with the Securities Exchange Commission. The reader is directed to these statements for a further discussion of important factors that could cause our actual results to differ materially from those in our forward-looking statements. You should note that the financial information in this press release is preliminary and subject to any adjustments that may be made in connection with the completion of our quarterly review procedures. We disclaim any intent or obligation to update these forward-looking statements.

Monday, July 18th, 2011 Uncategorized Comments Off on Valence Technology (VLNC) Announces Preliminary Fiscal First Quarter 2012 Results

Entree Gold (EGI) Ann Mason Project Drilling Returns Over 700 Metres of 0.49% Copper Equivalent

VANCOUVER, BRITISH COLUMBIA–(Marketwire – 07/14/11) – Entree Gold Inc. (TSX:ETG)(AMEX:EGI)(Frankfurt:EKA) (“Entree” or the “Company”) has received complete assay results from four additional deep diamond drill holes on the Ann Mason deposit in the Yerington district of Nevada. Three of the holes returned long intercepts (557 metres to 702 metres) averaging from 0.42% to 0.49% copper equivalent (“CuEq”). Intervals of higher grade mineralization occur in these holes, as shown in Table 1 below. Hole locations and cross sections can be viewed at www.entreegold.com.

Entree’s President & CEO, Greg Crowe, commented, “These latest results from our current program at Ann Mason support our belief that there is significant potential to expand the deposit, particularly to the west. In addition, these results have given us a better understanding of the geology and ore controls, which will be crucial when we begin construction of a robust deposit model after all of the results from the 2011 program are received. We are approximately half-way through the program for this year.”

Table 1. Significant intercepts from drill holes EG-AM-11-005, 007 and 009
----------------------------------------------------------------------------
                      From     To  Width      Cu     Au     Ag     Mo   CuEq
Hole                    (m)    (m)    (m)      %    g/t    g/t      %      %
----------------------------------------------------------------------------
EG-AM-11-005         138.8    496  357.2    0.39   0.05   1.01  0.004   0.44
  including            318    450    132    0.52   0.09   1.66  0.002   0.58
----------------------------------------------------------------------------
EG-AM-11-007           552   1072    520    0.37   0.02   0.55  0.009   0.42
  including            818    882     64    0.55   0.04   0.99  0.016   0.65
----------------------------------------------------------------------------
EG-AM-11-009            66    768    702    0.41   0.03   0.96  0.011   0.49
  including            268    396    128    0.52   0.02   0.74  0.012   0.59
  and                  554    768    214    0.48   0.07   1.92  0.017   0.60
----------------------------------------------------------------------------
(i) Copper equivalent is calculated using assumed metal prices of: copper
US$2.50/lb; molybdenum US$15.00/lb; gold US$1000/oz; and silver US$15.00/oz
and assumed recoveries relative to copper of: molybdenum 70%; gold 85%; and
silver 85%.

Discussion of Results

Hole EG-AM-11-005 is located on the north side of the deposit, 220 metres northeast of EG-AM-10-002 (refer to April 29, 2011 news release). The hole returned 357 metres averaging 0.44% CuEq starting from 138.8 metres depth and with a significant higher grade interval of 132 metres averaging 0.58% CuEq. This extends mineralization 100 metres north from the nearest historic hole with mineralization remaining open to the north.

Hole EG-AM-10-007 is the most westerly Entree hole drilled to date and is located 100 metres northwest of EG-AM-10-003 and 200 metres west of EG-AM-10-001. This hole returned 520 metres of 0.42% CuEq, starting at 552 metres, and includes a higher grade intersection of 64 metres averaging 0.65% CuEq. This extends the western limit of known mineralization, which remains open to further extension to the west and south.

Hole EG-AM-11-009 is an infill hole located in the south-central part of the deposit, approximately 230 metres southeast of EG-AM-10-002. The hole returned robust grades from near surface (702 metres of 0.49% CuEq), which extend 200 metres deeper than previous drilled intercepts, and confirm that the deposit remains open to the south.

Hole EG-AM-11-006, a step-out hole located on the southwest fringe of the deposit, encountered pyrite-dominant mineralization to around 1,000 metres depth before transitioning to more copper-rich mineralization. The results from this hole contribute to understanding the attitude and controls on mineralization in the western part of the deposit. Results from Hole EG-AM-11-008 are pending.

In addition to better defining the copper grade distribution and mineralogy, the current drilling is defining the content and distribution of molybdenum, gold and silver within the deposit. These elements were not systematically assayed during historical drilling programs, and in some holes (e.g. Hole 005) are significant contributors to higher copper equivalent numbers reported herein.

Planned Work

The Company has two diamond drills operating at Ann Mason to expand and better define the inferred resource of 810 million tonnes grading 0.40% Cu (more than 7 billion pounds of contained copper). To date, eleven holes totalling 12,940 metres have been completed and an additional two holes are in progress. Results for three completed holes are pending. The current program plans for an additional seven holes, for a planned 2011 total of approximately 20,000 metres.

QUALITY ASSURANCE AND CONTROL

Split core samples were prepared and analyzed at ALS Minerals in Reno, Nevada and Vancouver, British Columbia. Prepared standards, blanks and duplicates are inserted at the project site to monitor the quality control of the assay data. Drill intersections described in this news release are based on core lengths and may not reflect the true width of mineralization.

QUALIFIED PERSON

Robert Cann, P.Geo., Entree’s Vice-President Exploration, a Qualified Person as defined by National Instrument 43-101 (“NI 43-101”), has reviewed the technical information contained in this release.

ABOUT ENTREE GOLD INC.

Entree Gold Inc. is a Canadian mineral exploration company focused on the worldwide exploration and development of copper and gold prospects. The Company’s flagship Lookout Hill property in Mongolia completely surrounds the Oyu Tolgoi project of Oyu Tolgoi LLC, a subsidiary of Ivanhoe Mines and the Government of Mongolia. A portion of the Lookout Hill property is subject to a joint venture with Oyu Tolgoi LLC. The joint venture property hosts the Hugo North Extension copper-gold deposit and the Heruga copper-gold-molybdenum deposit. Excellent exploration potential remains on the joint venture property for the discovery of additional mineralized zones.

In North America, the Company is exploring for porphyry-related copper systems in Nevada, Arizona and New Mexico. The primary asset is the Ann Mason property in Nevada, which hosts an inferred mineral resource estimate containing approximately 7 billion pounds of copper and considerable potential for additional targets.

The Company is also seeking additional opportunities to utilize its expertise in exploring for deep and/or concealed ore deposits. With a treasury of approximately CAD$15 million, the Company is well-funded for future activities. Rio Tinto and Ivanhoe Mines are major shareholders of Entree, holding approximately 13% and 12% of issued and outstanding shares, respectively.

This News Release contains forward-looking statements and forward-looking information (together, “forward-looking statements”) within the meaning of applicable securities laws and the United States Private Securities Litigation Reform Act of 1995, with respect to the potential for discovery of additional mineralized zones in Mongolia, the potential for expansion of the Ann Mason deposit and for identification of new targets on the Ann Mason property, and plans for future exploration and/or development programs and budgets. These forward-looking statements are made as of the date of this news release. Users of forward-looking statements are cautioned that actual results may vary from the forward-looking statements contained herein. While the Company has based these forward-looking statements on its expectations about future events as at the date that such statements were prepared, the statements are not a guarantee of the Company’s future performance and are subject to risks, uncertainties, assumptions and other factors which could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. Such factors and assumptions include, among others, the effects of general economic conditions, the prices of copper, gold and molybdenum, changing foreign exchange rates and actions by government authorities, uncertainties associated with legal proceedings and negotiations and misjudgements in the course of preparing forward-looking statements. In addition, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Known risk factors are described in the Company’s Annual Information Form for the financial year ended December 31, 2010, dated March 25, 2011 filed with the Canadian Securities Administrators and available at www.sedar.com. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company is under no obligation to update or alter any forward-looking statements except as required under applicable securities laws.

Thursday, July 14th, 2011 Uncategorized Comments Off on Entree Gold (EGI) Ann Mason Project Drilling Returns Over 700 Metres of 0.49% Copper Equivalent

Neuralstem (CUR) Announces Notice of Allowance for Two Additional Neurogenic Compound Patents

ROCKVILLE, Md., July 14, 2011 /PRNewswire/ — Neuralstem, Inc. (NYSE Amex: CUR) announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: “Compositions to Effect Neuronal Growth.” The patents cover three new compounds and include both structure and method claims for inducing neurogenesis and the growth of new neurons, both in-vitro and in-vivo.

(Logo: http://photos.prnewswire.com/prnh/20061221/DCTH007LOGO )

Neuralstem’s first neurogenic patented compound is currently in a Phase I FDA-approved safety trial in major depressive disorder. The Phase Ia trial, which is in healthy volunteers, is scheduled to be completed in August. The Phase Ib safety trial in depressed patients is expected to commence this fall.

“These patents cover additional new chemical entities from our neurogenic program and broaden our potential clinical development pipeline,” said Karl Johe, Ph.D., Neuralstem Chairman and Chief Scientific Officer. “Our proprietary neural stem cell technology allows for a unique window into the process of neurogenesis. Through this, we’ve discovered novel chemical compounds that are truly neurogenic. We believe that our portfolio of neurogenic compounds will be at the forefront of novel treatments for psychiatric and cognitive diseases that focus on neural regeneration, not just brain chemistry.”

“This is also an important validation of our screening platform,” said Richard Garr, Neuralstem President & CEO. “We are not only able to identify neurogenic and neuroprotective compounds by screening against our cells, but we can also identify novel, patentable compounds, across a diverse chemical library. As the patents run out across the industry on many CNS drugs, we believe Neuralstem is well-positioned to provide value to our future development partners.”

About Neuralstem

Neuralstem’s patented technology enables the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells constitutively into mature, physiologically relevant human neurons and glia. Neuralstem is in an FDA-approved Phase I safety clinical trial for amyotrophic lateral sclerosis (ALS), often referred to as Lou Gehrig‘s disease and has been awarded orphan status designation by the FDA.

In addition to ALS, the company is also targeting major central nervous system conditions with its cell therapy platform, including spinal cord injury, ischemic spastic paraplegia, chronic stroke, and Huntington‘s disease. The company has submitted an IND (Investigational New Drug) application to the FDA for a Phase I safety trial in chronic spinal cord injury.

Neuralstem also has the ability to generate stable human neural stem cell lines suitable for the systematic screening of large chemical libraries. Through this proprietary screening technology, Neuralstem has discovered and patented compounds that may stimulate the brain’s capacity to generate new neurons, possibly reversing the pathologies of some central nervous system conditions. The company has commenced an FDA-approved Phase Ia safety trial evaluating NSI-189, its first small molecule compound, for the treatment of major depression. Additional indications could include schizophrenia, Alzheimer’s disease and bipolar disorder.

For more information, please go to www.neuralstem.com.

Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements in this press release regarding potential applications of Neuralstem’s technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in Neuralstem’s periodic reports, including the annual report on Form 10-K for the year ended December 31, 2010 and the quarterly report on Form 10-Q for the period ended March 31, 2011.

Thursday, July 14th, 2011 Uncategorized Comments Off on Neuralstem (CUR) Announces Notice of Allowance for Two Additional Neurogenic Compound Patents

Rosetta Genomics (ROSG) Launches miRview(R) Lung Test

PHILADELPHIA, PA and REHOVOT, ISRAEL–(Marketwire – 07/14/11) – Rosetta Genomics (NASDAQ:ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, announces that it has launched miRview® lung, the Company’s advanced microRNA test that differentiates neuroendocrine tumors from non-small cell lung tumors (NSCLC), and then further subtypes neuroendocrine tumors into small cell lung cancer and carcinoid; and subtypes NSCLC tumors into squamous and non-squamous. miRview® lung will be marketed in the U.S. by Rosetta Genomics’ oncology sales team and will be available internationally through the Company’s various distribution partners.

miRview® lung was developed to use small, pre-operative specimens to differentiate tumor types and to further subtype them. Small, pre-operative biopsies such as bronchoscopic washing, brushing, fine-needle aspirate (FNA) and core needle biopsies are the most common methods for acquiring sample from lung tumors; however, in 20% to 30% of these pre-operative cases significant limitations of tumor quantity and quality prevent full classification and subtyping of the tumor using traditional diagnostic methods, including H&E and immunohistochemical stains. Using the expression levels of eight microRNAs, Rosetta Genomics’ researchers developed a molecular classifier which was validated on an independent blinded validation set of 451 samples, with sensitivity of 93.7% in the identification of the four main subtypes of lung tumors. The sensitivity for cytological samples, which constitute more than half of the validation set, was 95%. miRview® lung joins miRview® squamous, the Company’s microRNA diagnostic test developed to subtype NSCLC for resection and FNA sample types, strengthening the suite of testing solutions offered by Rosetta for pre-operative samples from lung tumors.

Commenting on the clinical importance of this assay, Dr. Harvey Pass, Professor of Surgery and Cardiothoracic Surgery, Vice Chairman, Research Director, Division of Thoracic Surgery and Thoracic Oncology at NYU Langone Medical Center and Cancer Center, stated, “A standardized and objective assay, like miRview® lung, that results in the accurate identification of the tumor type in small biopsy samples from lung cancer patients has the potential to lead to better information and better decisions about the appropriate treatment approaches for these patients.”

“With the recent emergence of targeted lung cancer therapies, such as Avastin® and Alimta®, and with other targeted drugs entering the clinical arena, accurate classification and subtyping of lung cancer is becoming increasingly important to better assess differential side effects and efficacy profiles and to enhance treatment strategies. We believe there is a definite need for objective, standardized, and reproducible molecular diagnostic assays that can reliably classify and subtype lung cancer,” noted Kenneth A. Berlin, President and Chief Executive Officer of Rosetta Genomics, said, “We are especially pleased to add miRview® lung to our suite of microRNA oncology diagnostic tests as it has the potential to assist in the accurate classification and subtyping of many of the over one and a half million patients diagnosed with lung cancer each year.”

About miRview® Products
miRview® are a series of microRNA-based diagnostic products offered by Rosetta Genomics. miRview® mets and miRview® mets² accurately identify the primary tumor site in metastatic cancer and CUP. miRview® squamous accurately identifies the squamous subtype of non-small cell lung cancer, which carries an increased risk of severe or fatal internal bleeding and poor response to treatment for certain therapies. miRview® meso diagnoses mesothelioma, a cancer connected to asbestos exposure. miRview® lung accurately identifies the four main subtypes of lung cancer using small amounts of tumor cells. miRview® tests are designed to provide objective diagnostic data; it is the treating physician’s responsibility to diagnose and administer the appropriate treatment. In the U.S. alone, Rosetta Genomics estimates that approximately 200,000 patients a year may benefit from the miRview® mets and miRview® mets² test, 60,000 from miRview® squamous, 60,000 from miRview® meso and 222,000 from miRview® lung. The Company’s tests are offered directly by Rosetta Genomics in the U.S., and through distributors around the globe. For more information, please visit www.mirviewdx.com. Parties interested in ordering the test can contact Rosetta Genomics at (215) 382-9000 ext. 309.

About microRNAs
microRNAs (miRNAs) are recently discovered, small RNAs that act as master regulators of protein synthesis, and have been shown to be highly effective biomarkers. The unique advantage of microRNAs as biomarkers lies in their high tissue specificity, and their exceptional stability in the most routine preservation methods for biopsies, including Formalin Fixed Paraffin Embedded (FFPE) block tissue and fine needle aspirate (FNA) cell blocks. It has been suggested that their small size (19 to 21 nucleotides) enables them to remain intact in FFPE blocks, as opposed to messenger RNA (mRNA), which tends to degrade rapidly. In addition, early preclinical data has shown that by controlling the levels of specific microRNAs, cancer cell growth may be reduced. To learn more about microRNAs, please visit www.rosettagenomics.com.

About Rosetta Genomics
Rosetta Genomics develops and commercializes a full range of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development and commercialization of a full range of microRNA-based diagnostic tools. The Company’s miRview product line is commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. To learn more, please visit www.rosettagenomics.com.

Forward-Looking Statements
Various statements in this release concerning Rosetta’s future expectations, plans and prospects, including without limitation, statements relating to the need for and market potential of molecular diagnostic assays that can reliably classify and subtype lung cancer and the potential of microRNAs in the diagnosis and treatment of disease, constitute forward-looking statements for the purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta’s approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which may never lead to commercially accepted products or services; Rosetta’s ability to obtain, maintain and protect its intellectual property; Rosetta’s ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta’s need and ability to obtain additional funding to support its business activities; Rosetta’s dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta’s ability to successfully develop its products and services; Rosetta’s ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta’s technology; competition from others using technology similar to Rosetta’s and others developing products for similar uses; Rosetta’s dependence on collaborators; and Rosetta’s short operating history; as well as those risks more fully discussed in the “Risk Factors” section of Rosetta’s Annual Report on Form 20-F for the year ended December 31, 2010 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta’s views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

Thursday, July 14th, 2011 Uncategorized Comments Off on Rosetta Genomics (ROSG) Launches miRview(R) Lung Test

Hudson Technologies (HDSN) Announces Joint Venture Agreement to Establish Hudson Technologies Europe

PEARL RIVER, N.Y.–(BUSINESS WIRE)– Hudson Technologies, Inc. (NASDAQ:HDSNNews) announced that it has entered into a joint venture agreement with Europe-based Safety Hi-Tech S.r.l. (“SHT”) and the owners of the Italian engineering firm Banini-Binotti Associates (“BB”), for the development of reclamation, remediation and energy optimization services throughout most of Europe, the Middle East and North Africa. The European refrigerant aftermarket alone is estimated at over $700 million or approximately 70% of the U.S. refrigerant aftermarket. Additionally, due to the strict regulatory environment in Europe there is strong demand for the energy optimization and emissions reducing services Hudson provides.

The joint venture will create a new Italy-based company known as Hudson Technologies Europe S.r.l. Hudson and SHT will each own 40% of the new company and BB will own 20%. Using equipment and technology supplied and licensed by Hudson, the new company will market Hudson’s full suite of products and services, with an emphasis on Hudson’s energy optimization services. Hudson Technologies Europe will also provide reclamation support to SHT for the recycling and resale into the refrigeration market of refrigerants which are not only used in A/C systems but also used in most other fire suppression systems, including SHT’s. The parties have already made significant progress towards launching this joint venture, including the construction of equipment, facility layout and sourcing of refrigerants.

Hudson’s participation in this joint venture will further Hudson’s longer term growth strategy by:

  • Positioning Hudson to meet increasing European market demand for energy optimization solutions that is being driven by high energy costs and a stringent regulatory environment
  • Expanding Hudson’s opportunities to grow its reclamation business by taking advantage of Europe’s accelerated refrigerant phase out schedule; Virgin production of R-22 is currently 100% phased out in Europe and existing R-22 operating systems can only be serviced with reclaimed or recycled refrigerant that is presently selling at more than 3 times the price of R-22 in the U.S.
  • Capitalizing on a very fragmented and under developed EU reclamation market which has few facilities able to meet Hudson’s purity and performance standards
  • Providing immediate access to an established customer base and a well-developed infrastructure for the marketing of Hudson products and services in Europe, the Middle East and North Africa

The European Union (EU) is approximately five years ahead of the US in (i) the phase out of hydrochlorofluorocarbons (HCFCs), including R-22, (ii) carbon emission standards for greenhouse gases (“GHGs”), and (iii) efforts to increase energy efficiency. In the US, Hudson has been advancing in each of those areas ahead of government regulations and mandates, and in some instances ahead of market acceptance. Europe, however, has already created regulations and market incentives that Hudson believes support the offerings that the Company currently provides in the US. Consequently, Europe represents a promising and significant opportunity for Hudson, through the joint venture, to market and provide its services to industrial and commercial facilities.

Click here for additional information about EU’s environmental regulations and how they impact the market opportunity for Hudson Technology Europe.

Hudson’s ability to identify and capture energy efficiencies and savings in steam, air conditioning and refrigeration systems, typically the largest energy users in commercial or industrial facilities, we believe will enable the joint venture’s customers to save money, create reliable and verifiable emissions offsets and better comply with European government initiatives. Furthermore, whereas the U.S. phase out of Chlorofluorocarbons (“CFCs”) took place more than 15 years ago, many developing countries, which include most nations in the Middle East and North Africa, are only now undertaking the phase out of CFC-based refrigerants. We believe that these developing nations can benefit from Hudson’s phase out experience, providing long term opportunities for Hudson Technologies Europe to grow market share.

Kevin J. Zugibe, Chairman and Chief Executive Officer of Hudson Technologies commented, “This partnership with Safety High Tech and Messrs. Banini and Binotti advances our desire to identify markets for our services outside of the U.S. that will enable us to grow our market share. SHT’s existing fire suppression customers in Europe, the Middle East and Asia are primarily industrial customers and prime candidates for the services that Hudson Technologies Europe will provide. As government mandated phase outs and/or use restrictions of all refrigerants, including Hydrofluorocarbon (“HFC”), HCFC, and CFC-based substances create shortages and/or use restrictions of these gases, and as mandatory GHG reductions require the industry to reduce GHG emission, Hudson Technologies Europe will be in a position to provide reclamation and energy optimization services to the needs of SHT’s existing industrial customers. Additionally, our reclamation efforts give us access to the ozone depleting gases that have high value in the carbon credit market, a market that is currently significantly more active in Europe than in the U.S. We are excited by this opportunity and look forward to working with SHT and BB toward the success of this combined venture.”

Aldo Indovino, Safety Hi-Tech’s President, commented on the joint venture: “Hudson’s proven ability to provide proprietary on-site decontamination and energy optimization services makes this joint venture the perfect solution for the European market for many reasons. The opportunity to provide cost-effective energy optimization services, and the ability to access government incentive programs, will set this joint venture apart from others. We are also pleased to have Messrs. Banini and Binotti as part of this joint venture. They specialize in energy and environmental issues and will provide Hudson Technologies Europe with dedicated human resources to promote public awareness of the significant role of energy optimization for large comfort and process cooling systems as a part of the overall strategies to combat Global Warming.”

Stefano Binotti, one of the BB partners, commented on the new project, “Our participation in the Joint Venture represents a very significant moment for us. Both our American and Italian partners are companies with extensive knowledge and experience in their respective fields. We believe their combined technical and commercial expertise, synergistically integrated with our professional experience, will lead Hudson Technologies Europe to successfully develop its business in the European, North African and Middle Eastern markets.”

About Hudson Technologies

Hudson Technologies, Inc. is a leading provider of innovative solutions to recurring problems within the refrigeration industry. Hudson’s proprietary RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. Performed at a customer’s site as an integral part of an effective scheduled maintenance program or in response to emergencies, RefrigerantSide®Services offer significant savings to customers due to their ability to be completed rapidly and at higher purity levels, and can be utilized while the customer’s system continues to operate. In addition, the Company sells refrigerants and provides traditional reclamation services to the commercial and industrial air conditioning and refrigeration markets. For further information on Hudson, please visit the Company’s web site at www.hudsontech.com.

About Safety Hi-Tech

Safety Hi-Tech (“SHT”) is a customer-focused supplier of advanced solutions for the Fire-Fighting sector which serves customers and markets through a network of integrated sales, production, research and technical services. SHT is a pioneer in clean agent fire suppression technologies, providing a proprietary, patented alternative to Halon, a chemical compound derived from hydrocarbons which has been identified as a significant contributor to the destruction of the ozone layer. SHT’s patented NAF S 125 and NAF S 227 Fire Extinguishing Agents and Systems have gained worldwide acceptance and recognition from leading environmental and technical authorities and have achieved significant market share in several geographies in Europe and other locations around the world. SHT’s Fire Extinguishing Agents have been included in the US Environmental Protection Agency’ SNAP List as acceptable Halon 1301 replacements and have been approved by internationally recognized testing laboratories, including Underwriters Laboratories Inc. and the Loss Prevention Certification Board.

www.safetyhitech.com

About Banini & Binotti

Stefano Banini and Stefano Binotti are the owners of the engineering firm of Banini Binotti Associates (BB) and have been together since 1995. Since then, they have operated in Italy and abroad as consultancy suppliers for environmental and energy issues. The firm targets its services mainly to public companies and governmental institutions and generally acts as project managers and project developers. Through the support of specific skills, innovative perspectives and a professional staff, BB offers a full range of solutions and services in environmental engineering and sustainable development. Since the establishment of the firm, BB has operated as consultants to the Italian Ministry for the Environment Land and Sea. In 2008 they promoted the establishment of a Public Private Partnership between a number of Italian state-based universities and private companies. The firm now operates at both the national and international level, and is oriented to develop itself as an open network aimed at promoting a collaborative environment between the academic world, institutions and private/public companies.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Statements contained herein which are not historical facts constitute forward-looking statements. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, changes in the markets for refrigerants (including unfavorable market conditions adversely affecting the demand for, and the price of, refrigerants), the Company’s ability to source refrigerants, regulatory and economic factors, seasonality, competition, litigation, the nature of supplier or customer arrangements which become available to the Company in the future, adverse weather conditions, possible technological obsolescence of existing products and services, possible reduction in the carrying value of long-lived assets, estimates of the useful life of its assets, potential environmental liability, customer concentration, the ability to obtain financing, factors associated with the joint venture which include the ability of the parties to perform their obligations under the joint venture agreement, any delays or interruptions in bringing products and services to market, the timely availability of any requisite permits and authorizations from governmental entities and third parties as well as factors relating to doing business outside the U.S. including changes in the laws, regulations, policies, and political, financial and economic conditions, including inflation, interest and currency exchange rates, of countries in which the joint venture may seek to conduct business, and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission. The words “believe”, “expect”, “anticipate”, “may”, “plan”, “should” and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made.

Thursday, July 14th, 2011 Uncategorized Comments Off on Hudson Technologies (HDSN) Announces Joint Venture Agreement to Establish Hudson Technologies Europe

Dynatronics (DYNT) Signs Agreement With CHAMPS Group Purchasing

SALT LAKE CITY, July 14, 2011 /PRNewswire/ — Dynatronics Corporation (NASDAQ:DYNTNews) today announced the signing of an agreement with CHAMPS Group Purchasing to promote Dynatronics’ products to the 4,000 CHAMPS member facilities across the country. CHAMPS Group Purchasing is one of the leading affiliates of Premier Inc.’s group purchasing organization (GPO).

“We are very impressed with the broad product line and excellent service offered by Dynatronics,” stated Jan Elder, contracting director at CHAMPS Group Purchasing. “In our role of providing value to our members, we believe Dynatronics’ line of quality therapy devices and medical supplies will be very attractive to our member facilities.”

The signed pact with CHAMPS Group Purchasing includes Dynatronics’ therapy equipment and supplies, as well as the company’s Stream electronic patient communications platform.

“As a significant player in the group purchasing arena, CHAMPS is well positioned to facilitate the adoption of Dynatronics’ products and services throughout their chain,” stated Larry K. Beardall, executive vice president of sales and marketing of Dynatronics. “With their expertise in clinical products and needs, we are thrilled they have recognized the value and benefits we offer and have agreed to help promote our 12,000 products to their member facilities.”

“We believe this agreement is an important step forward in converting GPO business to our brand, and in strengthening our working relationship with the CHAMPS Group Purchasing,” added Beardall.

About CHAMPS Group Purchasing Organization

As healthcare group purchasing experts, CHAMPS helps the healthcare industry save money and lightens the contracting burden for purchasing managers. For nearly 19 years, CHAMPS Group Purchasing has been an affiliate of Premier, Inc., one of the largest healthcare buying groups in the country, with over $36 billion in volume and over 1,700 contracts. CHAMPS provides personal and expert service, aggregated contract portfolio and custom contract offerings to more than 4,000 clients nationwide. More information regarding CHAMPS GPO is available at www.CHAMPSGPO.com.

About Dynatronics

Dynatronics Corporation manufactures, markets and/or distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment, and patient engagement technology for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.

Thursday, July 14th, 2011 Uncategorized Comments Off on Dynatronics (DYNT) Signs Agreement With CHAMPS Group Purchasing

New Energy Systems Group (NEWN) Announces Addition to Russell Microcap Index

SHENZHEN, China, June 30, 2011 /PRNewswire-Asia-FirstCall/ — New Energy Systems Group (NYSE Amex: NEWN) (“New Energy” or the “Company”), a vertically-integrated original design manufacturer and distributor of lithium ion batteries and consumer branded backup power systems, today announced that it has been added to the Russell Microcap Index effective June 24, 2011.

Russell Investments, a leading financial services provider serving individual and institutional investors, rebalances its entire family of indexes every year to maintain true representation of global equity markets, capitalization and style. Companies are added and deleted from the various indices according to these changes. The Russell Microcap Index Fund had approximately $497 million of assets as of June 28, 2011.

New Energy Chairman Weihe Yu stated, “We are proud to be a part of an index that includes premier companies such as Orbitz Worldwide and Rosetta Stone. It signifies the progress New Energy has made in a short period of time. As we continue to execute our growth strategies in the years ahead, we will strive to deliver significant shareholder value.”

About New Energy Systems Group

New Energy Systems Group is a vertically integrated original design manufacturer and distributor of lithium ion batteries and backup power systems for leading manufacturers of mobile phones, laptops, digital cameras, MP3s and a variety of other portable electronics. The Company’s end-user consumer products are sold under the Anytone® brand in China while it’s commercial and OEM batteries and battery components are sold under New Power and E’Jenie. The fast pace of new mobile device introductions in China combined with a growing middle class make it fertile ground for New Energy’s end-user consumer products, as well as its high powered, light weight lithium ion batteries. In addition to historically strong organic growth, New Energy is expected to benefit from economies of scale, broader distribution and higher profit margins in 2011. Additional information about the company is available at: www.newenergysystemsgroup.com.

Forward Looking Statements

This release contains certain “forward-looking statements” relating to the business of the Company and its subsidiary and affiliated companies. These forward looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.

For more information, please contact:

COMPANY

New Energy Systems Group

Ken Lin, VP of Investor Relations

Tel: +1-917-573-0302

Email: ken@newenergysystemsgroup.com

Web: www.newenergysystemsgroup.com

INVESTOR RELATIONS

HC International, Inc.

John Mattio, SVP

Tel: US +1-212-301-7130

Email: john.mattio@hcinternational.net

Web: www.hcinternational.net

Wednesday, July 13th, 2011 Uncategorized Comments Off on New Energy Systems Group (NEWN) Announces Addition to Russell Microcap Index